{
  "meta": {
    "id": "test25",
    "title": "Vaccines and Cold Chain",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A 14-week-old infant is brought to a Primary Health Center for routine immunizations. During this visit, she receives all her scheduled vaccines, but the Rota Virus Vaccine (RVV) is unavailable due to a shortage. As a result, she misses her third dose of RVV and is advised to return when it's available. For optimal immunization scheduling, it's important to know the minimum recommended interval between the administration of the RVV and other vaccines if they are not given on the same day. What is this minimum recommended interval before administering the RVV, following the administration of other vaccines?",
      "options": [
        {
          "label": "A",
          "text": "1 day",
          "correct": false
        },
        {
          "label": "B",
          "text": "1 week",
          "correct": false
        },
        {
          "label": "C",
          "text": "3 weeks",
          "correct": true
        },
        {
          "label": "D",
          "text": "4 weeks",
          "correct": false
        }
      ],
      "correct_answer": "C. 3 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. 3 weeks</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 General rules for multiple vaccine administration :</li><li>\u2022 rules</li><li>\u2022 multiple vaccine administration</li><li>\u2022 2 live vaccines can be given together Live and killed vaccines can be given together Live vaccine should not be administered to immuno-deficient or immunosuppressed persons 2 live vaccines can be administered simultaneously at different sites (or at an interval of 3 weeks) Cholera vaccine and Yellow fever vaccine cannot be given together OPV is the only live vaccine where a single dose is not sufficient for immunization</li><li>\u2022 2 live vaccines can be given together</li><li>\u2022 2 live vaccines</li><li>\u2022 together</li><li>\u2022 Live and killed vaccines can be given together</li><li>\u2022 Live and killed vaccines</li><li>\u2022 together</li><li>\u2022 Live vaccine should not be administered to immuno-deficient or immunosuppressed persons</li><li>\u2022 Live vaccine</li><li>\u2022 not</li><li>\u2022 immuno-deficient or immunosuppressed</li><li>\u2022 2 live vaccines can be administered simultaneously at different sites (or at an interval of 3 weeks)</li><li>\u2022 2 live vaccines</li><li>\u2022 at different sites</li><li>\u2022 Cholera vaccine and Yellow fever vaccine cannot be given together</li><li>\u2022 Cholera vaccine and Yellow fever vaccine</li><li>\u2022 cannot</li><li>\u2022 together</li><li>\u2022 OPV is the only live vaccine where a single dose is not sufficient for immunization</li><li>\u2022 OPV</li><li>\u2022 only live vaccine</li><li>\u2022 single dose</li><li>\u2022 not sufficient</li><li>\u2022 immunization</li><li>\u2022 Rules for Live Vaccine and Immunoglobulin :</li><li>\u2022 Rules</li><li>\u2022 Live Vaccine and Immunoglobulin</li><li>\u2022 Live vaccines should not normally be given for 12 weeks after an injection of normal human Ig If a live vaccine has already been given, NHIg injection should be deferred for 2 weeks</li><li>\u2022 Live vaccines should not normally be given for 12 weeks after an injection of normal human Ig</li><li>\u2022 Live vaccines</li><li>\u2022 not</li><li>\u2022 12 weeks</li><li>\u2022 after</li><li>\u2022 normal human Ig</li><li>\u2022 If a live vaccine has already been given, NHIg injection should be deferred for 2 weeks</li><li>\u2022 live vaccine</li><li>\u2022 given,</li><li>\u2022 NHIg</li><li>\u2022 deferred</li><li>\u2022 2 weeks</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Two live vaccines can be administered simultaneously at different sites (or at an interval of 3 weeks )</li><li>\u27a4 Two live vaccines</li><li>\u27a4 administered</li><li>\u27a4 at different sites</li><li>\u27a4 interval</li><li>\u27a4 3 weeks</li><li>\u27a4 Ref : Park 26 th ed pg 111.</li><li>\u27a4 Ref</li><li>\u27a4 : Park 26 th ed pg 111.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "357f8402",
      "audio": ""
    },
    {
      "text": "During an immunization logistics workshop, attendees, who include healthcare professionals and logistics coordinators, are learning about the cold chain system used for vaccine storage at different levels. One of the topics covered is the appropriate cold chain equipment for vaccine storage at the regional level. Knowing the correct type of equipment used at each level of the cold chain is crucial for maintaining vaccine efficacy. Which type of cold chain equipment is primarily used at the regional level to store vaccines?",
      "options": [
        {
          "label": "A",
          "text": "Walk in Freezer",
          "correct": true
        },
        {
          "label": "B",
          "text": "Large Deep freezer",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ice line refrigerator",
          "correct": false
        },
        {
          "label": "D",
          "text": "Small Deep freezer",
          "correct": false
        }
      ],
      "correct_answer": "A. Walk in Freezer",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-160928_8DdLgqd.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Walk in Freezer</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Large Deep freezer : at district level , can store vaccine for 1 month, temperature is \u201315\u00b0C to \u201325\u00b0C</li><li>\u2022 Option B. Large Deep freezer</li><li>\u2022 district level</li><li>\u2022 1 month,</li><li>\u2022 \u201315\u00b0C to \u201325\u00b0C</li><li>\u2022 Option C. Ice line refrigerator ( ILR) : This is the most important component of the cold chain in India . Temperature of ILR (Cold chain) in India is +2\u00b0C to +8\u00b0C. ILR is used for storage of all vaccines . ILRs can maintain temperature of vaccines if provided with even 8 hours of uninterrupted electricity per day .</li><li>\u2022 Option C.</li><li>\u2022 Ice line refrigerator (</li><li>\u2022 ILR)</li><li>\u2022 cold chain</li><li>\u2022 India</li><li>\u2022 Temperature</li><li>\u2022 ILR (Cold chain)</li><li>\u2022 +2\u00b0C to +8\u00b0C.</li><li>\u2022 ILR</li><li>\u2022 storage</li><li>\u2022 all vaccines</li><li>\u2022 ILRs</li><li>\u2022 temperature of vaccines</li><li>\u2022 even 8 hours</li><li>\u2022 uninterrupted electricity per day</li><li>\u2022 Option D. Small Deep freezer : At PHC level, can store vaccine for 1 month, temperature is \u201315\u00b0C to \u201325\u00b0C</li><li>\u2022 Option D. Small Deep freezer</li><li>\u2022 PHC level,</li><li>\u2022 1 month,</li><li>\u2022 \u201315\u00b0C to \u201325\u00b0C</li><li>\u2022 Some important Pointers -</li><li>\u2022 Most important component of cold chain in India : ILR</li><li>\u2022 important</li><li>\u2022 component</li><li>\u2022 cold chain</li><li>\u2022 India</li><li>\u2022 ILR</li><li>\u2022 Minimum level of vaccine storage (in cold chain) in India: Primary health centre (below PHC level, vaccines are \u2018 transported to sub-centres on immunization days\u2019 in vaccine carriers and day carriers ).</li><li>\u2022 Minimum level</li><li>\u2022 Primary health centre</li><li>\u2022 transported to sub-centres</li><li>\u2022 immunization days\u2019</li><li>\u2022 vaccine carriers and day carriers</li><li>\u2022 Maximum chance of cold chain failure in India: Sub-centre and village level</li><li>\u2022 Maximum chance of cold chain</li><li>\u2022 failure</li><li>\u2022 Sub-centre and village level</li><li>\u2022 Instrument used to monitor the temperature of cold chain at PHC: Dial Thermometer.</li><li>\u2022 Instrument</li><li>\u2022 monitor</li><li>\u2022 temperature of cold chain</li><li>\u2022 Dial Thermometer.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cold chain components (equipments) and levels in India:</li><li>\u27a4 Cold chain components</li><li>\u27a4 levels in India:</li><li>\u27a4 Ref : Park 27th ed pg 118-120</li><li>\u27a4 Ref</li><li>\u27a4 : Park 27th ed pg 118-120</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ef9fc586",
      "audio": ""
    },
    {
      "text": "In a seminar on immunoglobulin therapy, a discussion arises about the World Health Organization (WHO) standards for Normal Human Immunoglobulin (NHIG) preparation. The speaker presents various criteria that define these standards and asks the audience to identify which of the given options is NOT included in the WHO standards for NHIG. This question aims to highlight a specific aspect of NHIG preparation that does not align with WHO guidelines.",
      "options": [
        {
          "label": "A",
          "text": "90% should be Ig G",
          "correct": false
        },
        {
          "label": "B",
          "text": "All IgG subclass should be present",
          "correct": false
        },
        {
          "label": "C",
          "text": "Should contain high concentration of Ig A",
          "correct": true
        },
        {
          "label": "D",
          "text": "Should contain antibody against at least 2 bacterial and viral species",
          "correct": false
        }
      ],
      "correct_answer": "C. Should contain high concentration of Ig A",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Should contain high concentration of IgA</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. 90% should be Ig G : Correct. This ensures the primary immunoglobulin in NHIG is IgG , known for its antibody activity against pathogens.</li><li>\u2022 Option A. 90% should be Ig G</li><li>\u2022 primary immunoglobulin</li><li>\u2022 NHIG</li><li>\u2022 IgG</li><li>\u2022 antibody</li><li>\u2022 activity against pathogens.</li><li>\u2022 Option B. All IgG subclass should be present : Correct. This is to maintain a broad spectrum of antibody activity .</li><li>\u2022 Option B. All IgG subclass should be present</li><li>\u2022 broad spectrum of antibody activity</li><li>\u2022 Option D. Should contain antibody against atleast 2 bacterial and viral species : Correct. This criterion ensures the NHIG is effective against a range of pathogens.</li><li>\u2022 Option D. Should contain antibody against atleast 2 bacterial and viral species</li><li>\u2022 ensures</li><li>\u2022 NHIG</li><li>\u2022 effective against</li><li>\u2022 range of pathogens.</li><li>\u2022 The Normal Human Immunoglobulin preparation should contain:</li><li>\u2022 Normal Human Immunoglobulin</li><li>\u2022 contain:</li><li>\u2022 At least 90 percent intact IgG It should be as free as possible from IgG aggregates All IgG sub-classes should be present There should be a low IgA concentration The level of antibody against at least two bacterial species and two viruses should be ascertained etc</li><li>\u2022 At least 90 percent intact IgG</li><li>\u2022 90 percent</li><li>\u2022 IgG</li><li>\u2022 It should be as free as possible from IgG aggregates</li><li>\u2022 free</li><li>\u2022 IgG aggregates</li><li>\u2022 All IgG sub-classes should be present</li><li>\u2022 IgG sub-classes</li><li>\u2022 present</li><li>\u2022 There should be a low IgA concentration</li><li>\u2022 low IgA concentration</li><li>\u2022 The level of antibody against at least two bacterial species and two viruses should be ascertained etc</li><li>\u2022 level of</li><li>\u2022 antibody against</li><li>\u2022 two bacterial species</li><li>\u2022 two viruses</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 WHO standards for Normal Human Immunoglobulin preparation , focus on the predominance of IgG (90%) and the presence of all IgG subclasses , and low concentration of IgA</li><li>\u27a4 WHO standards</li><li>\u27a4 Normal Human Immunoglobulin preparation</li><li>\u27a4 predominance</li><li>\u27a4 IgG (90%)</li><li>\u27a4 all IgG subclasses</li><li>\u27a4 low concentration</li><li>\u27a4 IgA</li><li>\u27a4 Ref : Park 26 th ed pg 115</li><li>\u27a4 Ref</li><li>\u27a4 : Park 26 th ed pg 115</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0505234c",
      "audio": ""
    },
    {
      "text": "A 9-month-old child who has not received any immunizations is brought to a Primary Health Centre in India. As per the Universal Immunization Programme (UIP) schedule followed in India, it is essential to determine which vaccines the child should receive at this age to catch up with the national immunization schedule. For a 9-month-old infant who is unimmunized, which of the following vaccines should be administered according to the UIP schedule?",
      "options": [
        {
          "label": "A",
          "text": "MR1, JE1, IPV, PCV and Vitamin A",
          "correct": true
        },
        {
          "label": "B",
          "text": "MR1, JE1, PCV and Vitamin A",
          "correct": false
        },
        {
          "label": "C",
          "text": "MMR1, JE1, PCV and Vitamin A",
          "correct": false
        },
        {
          "label": "D",
          "text": "MR1, JE1, PCV, DPT Booster and Vitamin A",
          "correct": false
        }
      ],
      "correct_answer": "A. MR1, JE1, IPV, PCV and Vitamin A",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-173401_atjAruH.jpg"
      ],
      "explanation": "<p><strong>Ans. A) MR1, JE1, IPV, PCV and Vitamin A</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Vaccines to be given in situations of delayed immunizations in India \u2013 9 month old unimmunized child comes for immunization first time -</li><li>\u2022 Vaccines</li><li>\u2022 delayed immunizations in India</li><li>\u2022 9 month old unimmunized child</li><li>\u2022 immunization first time</li><li>\u2022 BCG (Direct) OPV1 (3 successive doses 1 month apart, booster after 1 year of 3rd dose) Pentavalent-1 /DPT1 (3 successive doses 1 month apart, booster after 1 year of 3rd dose) + HepB1 (3 successive doses 1 month apart) + HiB1 (2 successive doses 1 month apart) Measles-1/MR-1 Vitamin A (1 Lac IU) IPV-1 PCV-1 JE-1 Rota V-1</li><li>\u2022 BCG (Direct)</li><li>\u2022 OPV1 (3 successive doses 1 month apart, booster after 1 year of 3rd dose)</li><li>\u2022 Pentavalent-1 /DPT1 (3 successive doses 1 month apart, booster after 1 year of 3rd dose) + HepB1 (3 successive doses 1 month apart) + HiB1 (2 successive doses 1 month apart)</li><li>\u2022 Measles-1/MR-1</li><li>\u2022 Vitamin A (1 Lac IU)</li><li>\u2022 IPV-1</li><li>\u2022 PCV-1</li><li>\u2022 JE-1</li><li>\u2022 Rota V-1</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cases of delayed immunization -</li><li>\u27a4 Ref: Park 26 th ed pg 135, NTAGI recommendations 2022</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 135, NTAGI recommendations 2022</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "357803e9",
      "audio": ""
    },
    {
      "text": "A Community Medicine SR is conducting a session with medical students on vaccine formulations and their components. During the session, the topic shifts to the use of adjuvants in vaccines and their specific roles. The pediatrician highlights the Diphtheria, Tetanus, and Pertussis (DTaP) vaccine, pointing out that it contains aluminum phosphate. The students are then asked to consider why aluminum phosphate is included in this vaccine. What is the primary role of aluminum phosphate in the DTaP vaccine?",
      "options": [
        {
          "label": "A",
          "text": "Detoxifies the micro organisms",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stabilizes the antigen",
          "correct": false
        },
        {
          "label": "C",
          "text": "Enhances the immune response",
          "correct": true
        },
        {
          "label": "D",
          "text": "Preservatives",
          "correct": false
        }
      ],
      "correct_answer": "C. Enhances the immune response",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Enhances the immune response</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Detoxifies the microorganisms : Preservatives are used to detoxify the microorganisms. Antibiotics are used during the manufacturing phase to prevent bacterial contamination of the tissue culture cells in which the viruses are grown .</li><li>\u2022 Option A. Detoxifies the microorganisms</li><li>\u2022 Preservatives</li><li>\u2022 detoxify</li><li>\u2022 microorganisms.</li><li>\u2022 Antibiotics</li><li>\u2022 used</li><li>\u2022 prevent bacterial contamination</li><li>\u2022 tissue culture cells</li><li>\u2022 viruses are grown</li><li>\u2022 Option B . Stabilizes the antigen: Stabilizers acts by controlling acidity (pH); stabilizing antigens through necessary steps in the manufacturing process, such as freeze drying ; and preventing antigens from adhering to the sides of glass vials with a resultant loss in immunogenicity .</li><li>\u2022 Option B</li><li>\u2022 Stabilizes the antigen:</li><li>\u2022 Stabilizers</li><li>\u2022 acidity (pH); stabilizing antigens</li><li>\u2022 freeze drying</li><li>\u2022 preventing antigens</li><li>\u2022 adhering</li><li>\u2022 glass vials</li><li>\u2022 resultant loss</li><li>\u2022 immunogenicity</li><li>\u2022 Examples - potassium or sodium salts, lactose, human serum albumin and a variety of animal proteins, such as gelatin and bovine serum albumin.</li><li>\u2022 potassium or sodium salts, lactose, human serum albumin</li><li>\u2022 gelatin</li><li>\u2022 bovine serum albumin.</li><li>\u2022 Option D. Preservatives: These are the chemicals (e.g. thiomersal, formaldehyde ) added to killed or subunit vaccines in order to inactivate viruses , detoxify bacterial toxins , and to prevent serious secondary infections as a result of bacterial or fungal contamination.</li><li>\u2022 Option D. Preservatives:</li><li>\u2022 thiomersal, formaldehyde</li><li>\u2022 killed or subunit vaccines</li><li>\u2022 inactivate viruses</li><li>\u2022 detoxify bacterial toxins</li><li>\u2022 prevent</li><li>\u2022 secondary</li><li>\u2022 infections</li><li>\u2022 bacterial or fungal contamination.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The role of adjuvants like aluminum phosphate in vaccines, which is to enhance the immune response to the antigen , as seen in the Diphtheria vaccine.</li><li>\u27a4 role of adjuvants</li><li>\u27a4 aluminum phosphate</li><li>\u27a4 enhance</li><li>\u27a4 immune response</li><li>\u27a4 antigen</li><li>\u27a4 Diphtheria vaccine.</li><li>\u27a4 Ref: Park 26 th ed pg 114</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 114</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3af75fba",
      "audio": ""
    },
    {
      "text": "A community health worker is conducting a routine immunization camp in a rural village. During her visit, she encounters a mother with a 10-month-old boy who has not been vaccinated due to the family's constant relocations. The mother is now eager to start her child's vaccinations. Given the child's age and lack of prior immunizations, the community health worker needs to recommend a combination of vaccines for immediate administration to catch up with the standard immunization schedule. Which combination of vaccines should she recommend for the 10-month-old boy to protect him against preventable diseases?",
      "options": [
        {
          "label": "A",
          "text": "\u200b\u200b\u200b\u200b\u200bBCG, pentavalent, OPV, Rotavirus, PCV, IPV, MR, JE and Vitamin A",
          "correct": true
        },
        {
          "label": "B",
          "text": "BCG, Pentavalent, OPV, Rotavirus, PCV, IPV and after 4 weeks MR, JE, Vitamin A",
          "correct": false
        },
        {
          "label": "C",
          "text": "BCG, DPT, Hepatitis B, OPV, Rotavirus, PCV, IPV",
          "correct": false
        },
        {
          "label": "D",
          "text": "BCG, DPT, OPV, Rotavirus, PCV, IPV, MR, JE and Vitamin A",
          "correct": false
        }
      ],
      "correct_answer": "A. \u200b\u200b\u200b\u200b\u200bBCG, pentavalent, OPV, Rotavirus, PCV, IPV, MR, JE and Vitamin A",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-170954_LHU9k98.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-173401.jpg"
      ],
      "explanation": "<p><strong>Ans. A) BCG, pentavalent, OPV, Rotavirus, PCV, IPV, MR, JE and Vitamin A</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 It is safe and effective to give BCG, Penta, OPV, IPV, MR, RVV, PCV and JE (where applicable) vaccines and Vitamin A at the same time to a 9-month-old child who has never been vaccinated.</li><li>\u2022 safe and effective</li><li>\u2022 BCG, Penta, OPV, IPV, MR, RVV, PCV</li><li>\u2022 JE</li><li>\u2022 vaccines</li><li>\u2022 Vitamin A</li><li>\u2022 9-month-old</li><li>\u2022 never</li><li>\u2022 vaccinated.</li><li>\u2022 If more than one injection has to be given in one limb then ensure that the distance between the two injection sites is at least 1 inch apart.</li><li>\u2022 more</li><li>\u2022 one injection</li><li>\u2022 given</li><li>\u2022 one limb</li><li>\u2022 distance between</li><li>\u2022 two injection sites</li><li>\u2022 1 inch apart.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Cases of delayed Immunization -</li><li>\u2022 Cases of delayed Immunization -</li><li>\u2022 Ref: Immunization handbook for health workers, 2018, MoHFW, GoI, pg 21; IAP Guidebook on Immunization</li><li>\u2022 Ref:</li><li>\u2022 Immunization handbook for health workers, 2018, MoHFW, GoI, pg 21; IAP Guidebook on Immunization</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "12e64a84",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman from Brazil arrives at a major international airport in India. She is scheduled to travel to various rural areas in India for a pilgrimage. She is in good health and has no history of recent illnesses. As the airport's medical officer reviewing her health documentation, you note that she has completed most recommended vaccinations for travel. Considering her origin and travel plans, which of the following vaccination certificates is most important to verify for her?",
      "options": [
        {
          "label": "A",
          "text": "Hepatitis A",
          "correct": false
        },
        {
          "label": "B",
          "text": "BCG",
          "correct": false
        },
        {
          "label": "C",
          "text": "Japanese encephalitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Yellow fever",
          "correct": true
        }
      ],
      "correct_answer": "D. Yellow fever",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Yellow fever</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hepatitis A: Hepatitis A vaccination is generally recommended for travelers to areas with high endemicity. It's not specifically required for entry into India .</li><li>\u2022 Option A. Hepatitis A:</li><li>\u2022 travelers</li><li>\u2022 high endemicity.</li><li>\u2022 not</li><li>\u2022 entry into India</li><li>\u2022 Option B. BCG: It's not a standard travel vaccine.</li><li>\u2022 Option B. BCG:</li><li>\u2022 not</li><li>\u2022 Option C. Japanese Encephalitis: This vaccine is recommended for travelers to Asia who will be spending a lot of time outdoors in rural areas , but it's not a standard requirement for entry into India.</li><li>\u2022 Option C. Japanese Encephalitis:</li><li>\u2022 travelers to Asia</li><li>\u2022 spending</li><li>\u2022 outdoors in rural areas</li><li>\u2022 not</li><li>\u2022 entry into India.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 India is a \u2018Yellow Fever receptive\u2019 area: Population is unvaccinated and susceptible to Yellow Fever . Under IHR Travellers must possess a valid International certificate of vaccination ( validity 10 days\u2013Lifelong ) against YF before they enter \u2018YF receptive areas\u2019</li><li>\u27a4 India is a \u2018Yellow Fever receptive\u2019 area: Population is unvaccinated and susceptible to Yellow Fever .</li><li>\u27a4 India</li><li>\u27a4 \u2018Yellow Fever receptive\u2019</li><li>\u27a4 unvaccinated</li><li>\u27a4 susceptible</li><li>\u27a4 Yellow Fever</li><li>\u27a4 Under IHR Travellers must possess a valid International certificate of vaccination ( validity 10 days\u2013Lifelong ) against YF before they enter \u2018YF receptive areas\u2019</li><li>\u27a4 IHR Travellers</li><li>\u27a4 valid International certificate</li><li>\u27a4 validity 10 days\u2013Lifelong</li><li>\u27a4 YF before</li><li>\u27a4 enter \u2018YF receptive areas\u2019</li><li>\u27a4 Ref : PARK 26 th ed 324</li><li>\u27a4 Ref</li><li>\u27a4 : PARK 26 th ed 324</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "83a57452",
      "audio": ""
    },
    {
      "text": "A medical student is reviewing concepts of immunology. While discussing active immunity, the student is asked to identify which of the following methods does NOT confer active immunity. Which option should the student choose?",
      "options": [
        {
          "label": "A",
          "text": "Exposure to infections",
          "correct": false
        },
        {
          "label": "B",
          "text": "Inoculation of Immunoglobulins",
          "correct": true
        },
        {
          "label": "C",
          "text": "Immunization with killed vaccine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Exposure to subclinical infection",
          "correct": false
        }
      ],
      "correct_answer": "B. Inoculation of Immunoglobulins",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Inoculation of Immunoglobulins</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Active immunity may be acquired in 3 ways:</li><li>\u2022 Active immunity may be acquired in 3 ways:</li><li>\u2022 Option A. Exposure to infections: Following clinical infection, e.g., chickenpox, rubella, and measles.</li><li>\u2022 Option A. Exposure to infections:</li><li>\u2022 clinical</li><li>\u2022 chickenpox, rubella, and measles.</li><li>\u2022 Option C. Immunization with killed vaccine: Following immunization with an antigen which may be a killed vaccine, a live attenuated vaccine, or toxoid.</li><li>\u2022 Option C. Immunization with killed vaccine:</li><li>\u2022 immunization</li><li>\u2022 antigen</li><li>\u2022 killed vaccine, a live attenuated vaccine, or toxoid.</li><li>\u2022 Option D. Exposure to subclinical infection: Following subclinical or inapparent infection, e.g., polio and diphtheria.</li><li>\u2022 Option D. Exposure to subclinical infection:</li><li>\u2022 inapparent</li><li>\u2022 polio and diphtheria.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Active immunity may be acquired through clinical or subclinical infection or immunization, while Immunoglobins render passive immunity.</li><li>\u27a4 Active immunity</li><li>\u27a4 acquired</li><li>\u27a4 clinical or subclinical infection or immunization,</li><li>\u27a4 Immunoglobins</li><li>\u27a4 passive immunity.</li><li>\u27a4 Ref: Park 26 th ed pg 109.</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 109.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e0ef4c92",
      "audio": ""
    },
    {
      "text": "A 28-year-old man, planning an adventurous journey to a region known for exotic infectious diseases, consults a travel clinic for necessary immunizations. During his visit, he receives a vaccine to protect against a specific pathogen prevalent in his travel destination. In the context of his body's immune response to this vaccine, which type of antibody will his immune system predominantly produce first? This initial antibody plays a pivotal role in the primary immune response, acting as the first line of defense against new pathogens.",
      "options": [
        {
          "label": "A",
          "text": "IgG",
          "correct": false
        },
        {
          "label": "B",
          "text": "IgM",
          "correct": true
        },
        {
          "label": "C",
          "text": "IgA",
          "correct": false
        },
        {
          "label": "D",
          "text": "IgD",
          "correct": false
        }
      ],
      "correct_answer": "B. IgM",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. IgM</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Types of immunoglobulins -</li><li>\u2022 Types of immunoglobulins -</li><li>\u2022 IgG: Comprises 85% of total serum immunoglobulins, largely extravascular , the only class of immunoglobulins to cross the placenta.</li><li>\u2022 IgG:</li><li>\u2022 85%</li><li>\u2022 total serum immunoglobulins,</li><li>\u2022 extravascular</li><li>\u2022 cross the placenta.</li><li>\u2022 IgM: Comprises 10% of total serum immunoglobulins , indicative of recent infection, has high agglutinating and complement-fixating ability.</li><li>\u2022 IgM:</li><li>\u2022 10% of total serum immunoglobulins</li><li>\u2022 recent infection,</li><li>\u2022 high agglutinating</li><li>\u2022 complement-fixating</li><li>\u2022 IgA: Comprises 15% of total serum immunoglobulins, predominantly found in secretions, primary defence mechanism at mucous membranes</li><li>\u2022 IgA:</li><li>\u2022 15% of total serum immunoglobulins,</li><li>\u2022 found</li><li>\u2022 secretions,</li><li>\u2022 defence</li><li>\u2022 mucous membranes</li><li>\u2022 IgD: Exact function not known</li><li>\u2022 IgD:</li><li>\u2022 not known</li><li>\u2022 IgE : Concentrated in submucous tissues , responsible for immediate allergic anaphylaxis reaction.</li><li>\u2022 IgE</li><li>\u2022 submucous tissues</li><li>\u2022 immediate allergic anaphylaxis reaction.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Identify IgM as the first type of antibody produced in the primary immune response following initial vaccination or antigen exposure .</li><li>\u27a4 Identify IgM</li><li>\u27a4 first</li><li>\u27a4 antibody</li><li>\u27a4 primary immune response</li><li>\u27a4 vaccination or antigen exposure</li><li>\u27a4 Ref : Park 26th ed pg 109.</li><li>\u27a4 Ref</li><li>\u27a4 : Park 26th ed pg 109.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3d4c5663",
      "audio": ""
    },
    {
      "text": "In a workshop on public health, a medical officer emphasizes the importance of herd immunity in preventing outbreaks. Later, during a breakout session, participants brainstorm on factors that influence herd immunity. Which of the following factors raised by a participant does NOT play a significant role in establishing or maintaining herd immunity?",
      "options": [
        {
          "label": "A",
          "text": "Subclinical infection",
          "correct": false
        },
        {
          "label": "B",
          "text": "Immunization of herd",
          "correct": false
        },
        {
          "label": "C",
          "text": "Herd structure",
          "correct": false
        },
        {
          "label": "D",
          "text": "Immunity through maternal antibodies",
          "correct": true
        }
      ],
      "correct_answer": "D. Immunity through maternal antibodies",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. \u00a0Immunity through maternal antibodies</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Occurrence of clinical and subclinical infection in the herd.</li><li>\u2022 Option A.</li><li>\u2022 clinical and subclinical infection</li><li>\u2022 Option B. Immunization of the herd.</li><li>\u2022 Option B. Immunization</li><li>\u2022 Option C. Herd structure (hosts, alternative animal hosts, insect vectors, environmental & social factors).</li><li>\u2022 Option C.</li><li>\u2022 Herd structure</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Herd immunity is the indirect protection from an infectious disease that happens when a population is immune either through vaccination or immunity developed through previous infection . It is neither possible nor necessary to achieve 100% herd immunity to control a disease . Herd immunity may be determined by Serological Surveys .</li><li>\u27a4 Herd immunity</li><li>\u27a4 indirect</li><li>\u27a4 protection</li><li>\u27a4 infectious disease</li><li>\u27a4 population</li><li>\u27a4 immune</li><li>\u27a4 vaccination or immunity</li><li>\u27a4 previous infection</li><li>\u27a4 neither</li><li>\u27a4 nor</li><li>\u27a4 achieve</li><li>\u27a4 100% herd immunity</li><li>\u27a4 control</li><li>\u27a4 disease</li><li>\u27a4 determined</li><li>\u27a4 Serological Surveys</li><li>\u27a4 Ref: Park 26 th ed pg 110.</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 110.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4e361a4e",
      "audio": ""
    },
    {
      "text": "A public health official is addressing a group of healthcare professionals about the critical role of vaccinations in controlling infectious diseases. The official emphasizes the concept of herd immunity, which occurs when a significant portion of a community is vaccinated, thereby providing indirect protection to those who are not vaccinated. This phenomenon can effectively prevent the spread of certain infectious diseases. However, not all diseases can be controlled through herd immunity. The official poses a question to the audience: Among following diseases, which one does NOT benefit from herd immunity?",
      "options": [
        {
          "label": "A",
          "text": "Diphtheria",
          "correct": false
        },
        {
          "label": "B",
          "text": "Poliomyelitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tetanus",
          "correct": true
        },
        {
          "label": "D",
          "text": "Measles",
          "correct": false
        }
      ],
      "correct_answer": "C. Tetanus",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-154429_HY7EM4y.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Tetanus</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Options: In the cases of Diphtheria (Option A), Poliomyelitis (Option B), and Measles (Option D ), the pathogens are transmitted between individuals , and a high level of community immunity can prevent their spread, protecting even those who are not immunized . High vaccination rates in a population can provide herd immunity , reducing the likelihood of outbreaks .</li><li>\u2022 Options:</li><li>\u2022 Diphtheria (Option A), Poliomyelitis (Option B), and Measles (Option D</li><li>\u2022 pathogens</li><li>\u2022 transmitted</li><li>\u2022 between individuals</li><li>\u2022 high level</li><li>\u2022 prevent</li><li>\u2022 protecting</li><li>\u2022 not immunized</li><li>\u2022 High vaccination rates</li><li>\u2022 herd immunity</li><li>\u2022 reducing</li><li>\u2022 outbreaks</li><li>\u2022 Herd Immunity is the level of resistance of a community or group of people to a particular disease . It refers to group protection beyond what is afforded by the protection of immunized individuals . It helps to protect vulnerable people like babies , the elderly and to those who are immunocompromised.</li><li>\u2022 Herd Immunity</li><li>\u2022 level of resistance</li><li>\u2022 particular disease</li><li>\u2022 group protection</li><li>\u2022 afforded</li><li>\u2022 protection of immunized individuals</li><li>\u2022 protect vulnerable people</li><li>\u2022 babies</li><li>\u2022 elderly</li><li>\u2022 immunocompromised.</li><li>\u2022 Elements contributing to herd immunity are the occurrence of clinical/subclinical infections in herd, immunization of the herd , and structure of the herd (hosts, alternative animal hosts, insect vectors, environmental & social factors). It is neither possible nor necessary to achieve 100% herd immunity to control a disease . Herd immunity may be determined by Serological Surveys . Herd immunity describes a type of immunity that occurs when the vaccination of a portion of the population (or herd) protects un-vaccinated individuals .</li><li>\u2022 Elements contributing to herd immunity are the occurrence of clinical/subclinical infections in herd, immunization of the herd , and structure of the herd (hosts, alternative animal hosts, insect vectors, environmental & social factors).</li><li>\u2022 Elements</li><li>\u2022 herd immunity</li><li>\u2022 clinical/subclinical</li><li>\u2022 infections in herd, immunization</li><li>\u2022 herd</li><li>\u2022 structure</li><li>\u2022 herd</li><li>\u2022 It is neither possible nor necessary to achieve 100% herd immunity to control a disease .</li><li>\u2022 neither possible nor necessary</li><li>\u2022 100% herd immunity</li><li>\u2022 control a disease</li><li>\u2022 Herd immunity may be determined by Serological Surveys .</li><li>\u2022 determined</li><li>\u2022 Serological Surveys</li><li>\u2022 Herd immunity describes a type of immunity that occurs when the vaccination of a portion of the population (or herd) protects un-vaccinated individuals .</li><li>\u2022 Herd immunity</li><li>\u2022 type of immunity</li><li>\u2022 vaccination</li><li>\u2022 population (or herd) protects un-vaccinated individuals</li><li>\u2022 Herd Immunity Threshold</li><li>\u2022 Herd Immunity Threshold</li><li>\u2022 Virologists have found that when a certain percentage of a population is vaccinated , the spread of the disease is effectively stopped ;</li><li>\u2022 Virologists</li><li>\u2022 certain percentage</li><li>\u2022 population</li><li>\u2022 vaccinated</li><li>\u2022 spread</li><li>\u2022 disease</li><li>\u2022 effectively stopped</li><li>\u2022 This critical percentage (HIT) depends on the disease and the vaccine:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Herd immunity is effective in controlling diseases spread from person to person like Diptheria, polio, measles , but it does not apply to disease such as tetanus , where infection occurs through environmental exposure .</li><li>\u27a4 Herd immunity</li><li>\u27a4 controlling diseases</li><li>\u27a4 person to person</li><li>\u27a4 Diptheria, polio, measles</li><li>\u27a4 does not</li><li>\u27a4 tetanus</li><li>\u27a4 infection</li><li>\u27a4 environmental exposure</li><li>\u27a4 Ref: Park 26 th ed pg 111</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 111</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7afb351c",
      "audio": ""
    },
    {
      "text": "A 39-year-old woman visits your clinic for pre-travel health advice. She is planning a humanitarian mission to a rural area in Africa and is seeking guidance on necessary immunizations. During the consultation, you evaluate her health history and current medical status to determine the suitability of live vaccines for her. Given her specific health profile, you need to identify which aspect of her medical history does NOT constitute a contraindication to receiving live vaccines. This particular attribute, despite being a part of her health background, does not automatically disqualify her from receiving live vaccines.",
      "options": [
        {
          "label": "A",
          "text": "Recent initiation of chemotherapy for breast cancer",
          "correct": false
        },
        {
          "label": "B",
          "text": "Systemic lupus erythematosus (SLE) under immunosuppressive therapy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Asymptomatic HIV Infection",
          "correct": true
        },
        {
          "label": "D",
          "text": "Current pregnancy",
          "correct": false
        }
      ],
      "correct_answer": "C. Asymptomatic HIV Infection",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. \u00a0Asymptomatic HIV infection</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Recent initiation of chemotherapy for breast cancer:  Immunosuppression is the contraindication for live vaccine .</li><li>\u2022 Option A. Recent initiation of chemotherapy for breast cancer:  Immunosuppression</li><li>\u2022 contraindication</li><li>\u2022 live vaccine</li><li>\u2022 Option B. Systemic lupus erythematosus (SLE) under immunosuppressive therapy: Patients on immunosuppressive therapy, such as those with SLE, are generally advised against live vaccines due to the heightened risk of vaccine-induced disease .</li><li>\u2022 Option B. Systemic lupus erythematosus (SLE) under immunosuppressive therapy:</li><li>\u2022 advised</li><li>\u2022 live vaccines</li><li>\u2022 heightened risk</li><li>\u2022 vaccine-induced disease</li><li>\u2022 Option D. Current pregnancy: All live vaccines are contraindicated in Pregnancy EXCEPT Yellow fever vaccine</li><li>\u2022 Option D. Current pregnancy:</li><li>\u2022 All live vaccines</li><li>\u2022 contraindicated</li><li>\u2022 Pregnancy</li><li>\u2022 EXCEPT Yellow fever vaccine</li><li>\u2022 Some important pointers related to Vaccine Contraindication s -</li><li>\u2022 Vaccine Contraindication</li><li>\u2022 Vaccines contraindicated in Pregnancy : All live vaccines EXCEPT Yellow fever vaccine Vaccines contraindicated in Immuno-suppression : All live vaccines Vaccines contraindicated in Corticosteroid therapy : All live vaccines Vaccines contraindicated in fever : Typhoid vaccines (Typhoral; Typhim \u2013 Vi; TAB) Vaccines contraindicated in ARTI/diarrhoea : NONE Vaccines contraindicated together : Yellow fever and Cholera vaccine Vaccine contraindicated in Preterm-premature baby with birth weight < 2 kg : Hepatitis B Vaccines contraindicated in age < 1 year (infants): Yellow fever vaccine; Meningococcal vaccine and Pneumococcal vaccine Vaccines contraindicated in age < 2 years : Meningococcal vaccine; Pneumococcal vaccine and Typhoid vaccines Vaccine contraindicated in progressive neurological disease : Pertussis vaccine (Pertussis vaccine is not contraindicated in epilepsy controlled on medications, Cerebral palsy). Only absolute contraindication to killed vaccines : Severe local or general reaction to a previous dose.</li><li>\u2022 Vaccines contraindicated in Pregnancy : All live vaccines EXCEPT Yellow fever vaccine</li><li>\u2022 Pregnancy</li><li>\u2022 EXCEPT Yellow fever vaccine</li><li>\u2022 Vaccines contraindicated in Immuno-suppression : All live vaccines</li><li>\u2022 Immuno-suppression</li><li>\u2022 All live vaccines</li><li>\u2022 Vaccines contraindicated in Corticosteroid therapy : All live vaccines</li><li>\u2022 in Corticosteroid therapy</li><li>\u2022 All live vaccines</li><li>\u2022 Vaccines contraindicated in fever : Typhoid vaccines (Typhoral; Typhim \u2013 Vi; TAB)</li><li>\u2022 fever</li><li>\u2022 Typhoid vaccines</li><li>\u2022 Vaccines contraindicated in ARTI/diarrhoea : NONE</li><li>\u2022 in ARTI/diarrhoea</li><li>\u2022 NONE</li><li>\u2022 Vaccines contraindicated together : Yellow fever and Cholera vaccine</li><li>\u2022 contraindicated together</li><li>\u2022 Yellow fever and Cholera vaccine</li><li>\u2022 Vaccine contraindicated in Preterm-premature baby with birth weight < 2 kg : Hepatitis B</li><li>\u2022 Preterm-premature baby</li><li>\u2022 with birth weight < 2 kg</li><li>\u2022 Hepatitis B</li><li>\u2022 Vaccines contraindicated in age < 1 year (infants): Yellow fever vaccine; Meningococcal vaccine and Pneumococcal vaccine</li><li>\u2022 age < 1 year (infants):</li><li>\u2022 Yellow fever vaccine; Meningococcal vaccine and Pneumococcal vaccine</li><li>\u2022 Vaccines contraindicated in age < 2 years : Meningococcal vaccine; Pneumococcal vaccine and Typhoid vaccines</li><li>\u2022 age < 2 years</li><li>\u2022 Meningococcal vaccine; Pneumococcal vaccine and Typhoid vaccines</li><li>\u2022 Vaccine contraindicated in progressive neurological disease : Pertussis vaccine (Pertussis vaccine is not contraindicated in epilepsy controlled on medications, Cerebral palsy).</li><li>\u2022 progressive neurological disease</li><li>\u2022 Pertussis vaccine</li><li>\u2022 Only absolute contraindication to killed vaccines : Severe local or general reaction to a previous dose.</li><li>\u2022 absolute contraindication to killed vaccines</li><li>\u2022 Severe</li><li>\u2022 general reaction</li><li>\u2022 previous dose.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Live vaccines should not be administered to persons with immune deficiency diseases or to persons whose immune response may be suppressed because of leukaemia, lymphoma or malignancy or because of therapy with corticosteroids, alkylating agents, antimetabolic agents, or radiation, Pregnancy.</li><li>\u27a4 Live vaccines</li><li>\u27a4 not</li><li>\u27a4 immune deficiency diseases</li><li>\u27a4 immune response</li><li>\u27a4 suppressed</li><li>\u27a4 leukaemia, lymphoma</li><li>\u27a4 malignancy</li><li>\u27a4 corticosteroids, alkylating agents, antimetabolic agents, or radiation, Pregnancy.</li><li>\u27a4 Ref: Park 26 th ed pg 111.</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 111.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a7c65aa2",
      "audio": ""
    },
    {
      "text": "During a practical examination, you encounter a question related to vaccine types. You are presented with a set of vaccines and asked to identify which one is NOT a live attenuated vaccine. Live attenuated vaccines are made from a weakened form of the virus or bacteria, but one of the vaccines listed is prepared differently. Based on its method of preparation, which of the following vaccines is not a live attenuated vaccine?",
      "options": [
        {
          "label": "A",
          "text": "Sabin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rotavirus",
          "correct": false
        },
        {
          "label": "C",
          "text": "17-D",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rabies",
          "correct": true
        }
      ],
      "correct_answer": "D. Rabies",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/23/screenshot-2023-08-11-1921039026_SBEBAIV.jpg"
      ],
      "explanation": "<p><strong>Ans. D. Rabies</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Sabin: Live attenuated Oral Polio Vaccine</li><li>\u2022 Option A. Sabin:</li><li>\u2022 Live attenuated Oral Polio Vaccine</li><li>\u2022 Option B. Rota virus: Live attenuated oral vaccine</li><li>\u2022 Option B. Rota virus: Live attenuated oral vaccine</li><li>\u2022 Option C. 17 D - Live attenuated , lyophilized (Freeze dried) Yellow fever vaccine</li><li>\u2022 Option C. 17 D</li><li>\u2022 Live attenuated</li><li>\u2022 lyophilized</li><li>\u2022 Yellow fever vaccine</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Park 26 th ed pg 111.</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 111.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b10f90c2",
      "audio": ""
    },
    {
      "text": "In a clinical immunology lecture, the topic of interaction between live vaccines and Normal Human Immunoglobulin (NHIG) administration is discussed. The lecturer emphasizes the importance of timing when administering NHIG after a live vaccine to avoid diminishing the vaccine's efficacy. The students are then asked to determine the recommended minimum interval that should elapse after administering a live vaccine before NHIG can be safely given. This interval is crucial to ensure that the live vaccine has sufficient time to elicit an effective immune response before NHIG is introduced.",
      "options": [
        {
          "label": "A",
          "text": "2 weeks",
          "correct": true
        },
        {
          "label": "B",
          "text": "4 weeks",
          "correct": false
        },
        {
          "label": "C",
          "text": "6 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "12 weeks",
          "correct": false
        }
      ],
      "correct_answer": "A. 2 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. 2 weeks</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Live vaccines should not normally be given for 12 weeks after an injection of normal human Ig , and if a live vaccine has already been given, NHIg injection should be deferred for 2 weeks as this may jeopardize the immune response to the vaccine .</li><li>\u27a4 Live vaccines</li><li>\u27a4 not</li><li>\u27a4 12 weeks</li><li>\u27a4 normal human Ig</li><li>\u27a4 live vaccine</li><li>\u27a4 NHIg</li><li>\u27a4 deferred</li><li>\u27a4 2 weeks</li><li>\u27a4 jeopardize</li><li>\u27a4 immune response</li><li>\u27a4 vaccine</li><li>\u27a4 Ref : Park 26 th ed pg 115</li><li>\u27a4 Ref</li><li>\u27a4 : Park 26 th ed pg 115</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1009746d",
      "audio": ""
    },
    {
      "text": "In a medical training session about the BCG vaccine, used for tuberculosis prevention, specific details regarding its preparation and administration are being discussed. The trainees are presented with various statements about the BCG vaccine and asked to identify which one is true. This question is designed to test their knowledge about the practical aspects of handling and administering the BCG vaccine.",
      "options": [
        {
          "label": "A",
          "text": "\u200b\u200b\u200b\u200b\u200b\u200b Distilled water is used as diluent for BCG vaccine",
          "correct": false
        },
        {
          "label": "B",
          "text": "The site for injection should be cleaned thoroughly with spirit",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mantoux test becomes positive after 48 hours of vaccination",
          "correct": false
        },
        {
          "label": "D",
          "text": "WHO recommends Danish 1331 strain for vaccine production",
          "correct": true
        }
      ],
      "correct_answer": "D. WHO recommends Danish 1331 strain for vaccine production",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. WHO recommends Danish 1331 strain for vaccine production</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Distilled water is used as a diluent for the BCG vaccine: Incorrect. BCG is a lyophilized (freeze dried) vaccine and is reconstituted with Normal Saline as diluent and must be used within 1 hour of reconstitution</li><li>\u2022 Option A. Distilled water is used as a diluent for the BCG vaccine:</li><li>\u2022 lyophilized (freeze dried) vaccine</li><li>\u2022 reconstituted</li><li>\u2022 Normal Saline</li><li>\u2022 diluent</li><li>\u2022 used</li><li>\u2022 1 hour of reconstitution</li><li>\u2022 Option B. The site for injection should be cleaned thoroughly with spirit: Incorrect. Cleaning the injection site with spirit or alcohol- based solutions is actually not recommended for the BCG vaccine , as it can kill the live bacteria in the vaccine.</li><li>\u2022 Option B. The site for injection should be cleaned thoroughly with spirit:</li><li>\u2022 Cleaning</li><li>\u2022 injection site</li><li>\u2022 spirit or alcohol-</li><li>\u2022 not</li><li>\u2022 BCG vaccine</li><li>\u2022 kill the live bacteria</li><li>\u2022 vaccine.</li><li>\u2022 Option C. The Mantoux test becomes positive after 48 hours of vaccination :  Incorrect. The test does not become positive immediately after BCG vaccination . It takes 8\u201314 weeks to become positive after vaccination .</li><li>\u2022 Option C. The Mantoux test becomes positive after 48 hours of vaccination</li><li>\u2022 does not</li><li>\u2022 positive</li><li>\u2022 immediately</li><li>\u2022 BCG vaccination</li><li>\u2022 8\u201314 weeks</li><li>\u2022 positive</li><li>\u2022 vaccination</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 WHO recommended the Danish 1331 strain for BCG vaccine production, sterile saline is used as a diluent and Mantoux test takes 8\u201314 weeks to become positive after vaccination.</li><li>\u27a4 WHO</li><li>\u27a4 Danish 1331 strain</li><li>\u27a4 BCG vaccine</li><li>\u27a4 sterile saline</li><li>\u27a4 diluent</li><li>\u27a4 Mantoux test</li><li>\u27a4 8\u201314 weeks</li><li>\u27a4 positive</li><li>\u27a4 after vaccination.</li><li>\u27a4 Ref: Park 27/e p231</li><li>\u27a4 Ref:</li><li>\u27a4 Park 27/e p231</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "60625b5f",
      "audio": ""
    },
    {
      "text": "Mrs. X, an Auxiliary Nurse Midwife (ANM), is conducting an immunization session at her sub-centre. She has vaccinated three children with the MR (Measles-Rubella) vaccine from a 5-dose vial. After completing this session, she moves to the next village, where she needs to vaccinate one more child with the MR vaccine. Considering best practices in vaccine administration and safety, what should Mrs. X do with the opened MR vaccine vial to vaccinate the child in the new area?",
      "options": [
        {
          "label": "A",
          "text": "Use the same vial if not exceeded 4 hours from opening of vial",
          "correct": false
        },
        {
          "label": "B",
          "text": "If exceeded 4 hrs check for VVM, if VVM is there use the same vial",
          "correct": false
        },
        {
          "label": "C",
          "text": "Discard the old opened vial and use new vial",
          "correct": true
        },
        {
          "label": "D",
          "text": "Consult the medical officer",
          "correct": false
        }
      ],
      "correct_answer": "C. Discard the old opened vial and use new vial",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Discard the old opened vial and use new vial</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Use the same vial if not exceeded 4 hours from the opening of the vial: As there is change of location, so new vial for vaccinating the child in the new area . This practice ensures the potency and safety of the vaccine , adhering to strict vaccine handling and administration guidelines.</li><li>\u2022 Option A. Use the same vial if not exceeded 4 hours from the opening of the vial:</li><li>\u2022 new vial</li><li>\u2022 vaccinating</li><li>\u2022 new area</li><li>\u2022 ensures</li><li>\u2022 potency</li><li>\u2022 safety</li><li>\u2022 vaccine</li><li>\u2022 adhering</li><li>\u2022 strict vaccine handling</li><li>\u2022 administration guidelines.</li><li>\u2022 Option B. If exceeded 4 hours, check for VVM (Vaccine Vial Monitor): if it shows viability, use the same vial . Incorrect.</li><li>\u2022 Option B. If exceeded 4 hours, check for VVM (Vaccine Vial Monitor):</li><li>\u2022 viability,</li><li>\u2022 same vial</li><li>\u2022 Incorrect.</li><li>\u2022 Option D. Consult the medical officer: While consulting a medical officer is a good practice in uncertain situations, in this case, the standard protocol is to use a new vial .</li><li>\u2022 Option D. Consult the medical officer:</li><li>\u2022 consulting</li><li>\u2022 medical officer</li><li>\u2022 good practice</li><li>\u2022 uncertain</li><li>\u2022 standard protocol</li><li>\u2022 use</li><li>\u2022 new vial</li><li>\u2022 Open Vial Policy 2015</li><li>\u2022 Open Vial Policy 2015</li><li>\u2022 Not applicable for Vaccines : Measles, BCG, JE Applicable for Vaccines: OPV, DPT, Hepatitis B, TT, Liquid Pentavalent - Opened vaccine vials can be used in subsequent session \u2018 up to 4 weeks\u2019 .</li><li>\u2022 Not applicable for Vaccines : Measles, BCG, JE</li><li>\u2022 Not</li><li>\u2022 Vaccines</li><li>\u2022 Measles, BCG, JE</li><li>\u2022 Applicable for Vaccines: OPV, DPT, Hepatitis B, TT, Liquid Pentavalent - Opened vaccine vials can be used in subsequent session \u2018 up to 4 weeks\u2019 .</li><li>\u2022 Applicable</li><li>\u2022 OPV, DPT, Hepatitis B, TT, Liquid Pentavalent -</li><li>\u2022 used</li><li>\u2022 subsequent session</li><li>\u2022 \u2018</li><li>\u2022 4 weeks\u2019</li><li>\u2022 The expiry date should not pass, VVM within usability limits , Cold chain maintenance. Vaccine vial septum not submerged in water or contaminated , Aseptic technique used to withdraw doses . Record date and time of each vial opening.</li><li>\u2022 expiry date</li><li>\u2022 not</li><li>\u2022 VVM</li><li>\u2022 usability limits</li><li>\u2022 Cold chain</li><li>\u2022 Vaccine vial septum</li><li>\u2022 water</li><li>\u2022 contaminated</li><li>\u2022 Aseptic</li><li>\u2022 withdraw doses</li><li>\u2022 Record date</li><li>\u2022 time</li><li>\u2022 each vial opening.</li><li>\u2022 At end of session return all open vials to Cold chain - Reusable open vials : DPT, DT, Hepatitis B, Pentavalent Non-reusable open vials : Measles, BCG, JE ( Destroy after 48 hours or Next session whichever earlier ) If any AEFI reported: Store all vials in Cold chain till completion of investigation</li><li>\u2022 At end of session return all open vials to Cold chain - Reusable open vials : DPT, DT, Hepatitis B, Pentavalent Non-reusable open vials : Measles, BCG, JE ( Destroy after 48 hours or Next session whichever earlier ) If any AEFI reported: Store all vials in Cold chain till completion of investigation</li><li>\u2022 end of session</li><li>\u2022 all open vials</li><li>\u2022 Cold chain</li><li>\u2022 Reusable open vials : DPT, DT, Hepatitis B, Pentavalent Non-reusable open vials : Measles, BCG, JE ( Destroy after 48 hours or Next session whichever earlier ) If any AEFI reported: Store all vials in Cold chain till completion of investigation</li><li>\u2022 Reusable open vials : DPT, DT, Hepatitis B, Pentavalent</li><li>\u2022 Reusable open vials</li><li>\u2022 DPT, DT, Hepatitis B, Pentavalent</li><li>\u2022 Non-reusable open vials : Measles, BCG, JE ( Destroy after 48 hours or Next session whichever earlier )</li><li>\u2022 Non-reusable</li><li>\u2022 open vials</li><li>\u2022 Measles, BCG, JE</li><li>\u2022 Destroy after 48 hours</li><li>\u2022 Next session</li><li>\u2022 earlier</li><li>\u2022 If any AEFI reported: Store all vials in Cold chain till completion of investigation</li><li>\u2022 AEFI</li><li>\u2022 Store all vials</li><li>\u2022 Cold chain</li><li>\u2022 completion</li><li>\u2022 investigation</li><li>\u2022 RECENT UPDATE \u2013 Rotavirus vaccine is under Open Vial Policy .</li><li>\u2022 RECENT UPDATE</li><li>\u2022 Rotavirus vaccine</li><li>\u2022 Open Vial Policy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Vaccines like OPV, DPT, Hepatitis B, TT, Liquid Pentavalent, rota virus follow the Open vial policy , these can be used in subsequent sessions \u2018up to 4 weeks\u2019 . Open Vial Policy does not apply to Measles, BCG and Japanese Encephalitis (JE) vaccines.</li><li>\u27a4 OPV, DPT, Hepatitis B, TT, Liquid Pentavalent, rota virus</li><li>\u27a4 Open vial policy</li><li>\u27a4 used</li><li>\u27a4 subsequent sessions</li><li>\u27a4 4 weeks\u2019</li><li>\u27a4 Open Vial Policy</li><li>\u27a4 not</li><li>\u27a4 to Measles, BCG and Japanese Encephalitis (JE) vaccines.</li><li>\u27a4 Ref: Park 26 th ed pg 117</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 117</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a3127517",
      "audio": ""
    },
    {
      "text": "As the Medical Officer overseeing a primary health center, one of your responsibilities is to ensure the correct storage of vaccines. Proper storage is crucial for maintaining vaccine efficacy, particularly regarding their sensitivity to freezing temperatures. Among the vaccines commonly stored at your facility, you need to identify which one is most sensitive to freezing and requires the most careful temperature management to retain its effectiveness. Which of the following vaccines is known to be the most freeze-sensitive?",
      "options": [
        {
          "label": "A",
          "text": "OPV",
          "correct": false
        },
        {
          "label": "B",
          "text": "DPT",
          "correct": false
        },
        {
          "label": "C",
          "text": "IPV",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hepatitis B",
          "correct": true
        }
      ],
      "correct_answer": "D. Hepatitis B",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/10/image-20230710163422-1.png"
      ],
      "explanation": "<p><strong>Ans. D. Hepatitis B</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. OPV: More sensitive to heat . OPV is stored at +2\u00b0 to +8\u00b0C. Except for long-term storage when it\u2019s kept in a freezer (-15\u00b0 to -25\u00b0C)</li><li>\u2022 Option A. OPV:</li><li>\u2022 sensitive</li><li>\u2022 heat</li><li>\u2022 OPV</li><li>\u2022 +2\u00b0 to +8\u00b0C.</li><li>\u2022 long-term storage</li><li>\u2022 kept</li><li>\u2022 freezer (-15\u00b0 to -25\u00b0C)</li><li>\u2022 Option B. DPT: Stored at +2\u00b0 to +8\u00b0C . Both heat and cold sensitive but its sensitivity to freezing is not as critical as that of the Hepatitis B vaccine.</li><li>\u2022 Option B. DPT:</li><li>\u2022 Stored</li><li>\u2022 +2\u00b0 to +8\u00b0C</li><li>\u2022 heat and cold sensitive</li><li>\u2022 its sensitivity</li><li>\u2022 freezing</li><li>\u2022 not</li><li>\u2022 Hepatitis B vaccine.</li><li>\u2022 Option C. IPV: Stored at +2\u00b0 to +8\u00b0C .  Both heat and cold sensitive but its sensitivity to freezing is not as critical as that of the Hepatitis B vaccine.</li><li>\u2022 Option C. IPV:</li><li>\u2022 +2\u00b0 to +8\u00b0C</li><li>\u2022 heat and cold sensitive</li><li>\u2022 its sensitivity</li><li>\u2022 freezing</li><li>\u2022 not</li><li>\u2022 Hepatitis B vaccine.</li><li>\u2022 Note:</li><li>\u2022 Note:</li><li>\u2022 Under NIS, RCH Program all vaccines are stored in +2\u00b0 to +8\u00b0C. SHAKE TEST is used to check if freeze-sensitive vaccines have been damaged by exposure to freezing temperatures below 0 degrees C; after the test , the previously frozen vaccine shows flakes . Most Thermolabile vaccine : Reconstituted BCG Most Thermostable vaccine : TT</li><li>\u2022 Under NIS, RCH Program all vaccines are stored in +2\u00b0 to +8\u00b0C.</li><li>\u2022 NIS, RCH</li><li>\u2022 all vaccines</li><li>\u2022 stored</li><li>\u2022 +2\u00b0 to +8\u00b0C.</li><li>\u2022 SHAKE TEST is used to check if freeze-sensitive vaccines have been damaged by exposure to freezing temperatures below 0 degrees C; after the test , the previously frozen vaccine shows flakes .</li><li>\u2022 SHAKE TEST</li><li>\u2022 freeze-sensitive vaccines</li><li>\u2022 damaged</li><li>\u2022 exposure</li><li>\u2022 below</li><li>\u2022 0 degrees</li><li>\u2022 after</li><li>\u2022 test</li><li>\u2022 frozen</li><li>\u2022 shows flakes</li><li>\u2022 Most Thermolabile vaccine : Reconstituted BCG</li><li>\u2022 Thermolabile vaccine</li><li>\u2022 Reconstituted BCG</li><li>\u2022 Most Thermostable vaccine : TT</li><li>\u2022 Thermostable vaccine</li><li>\u2022 TT</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : Immunization handbook for health workers, 2018, MoHFW, GoI, pg 69.</li><li>\u27a4 Ref</li><li>\u27a4 : Immunization handbook for health workers, 2018, MoHFW, GoI, pg 69.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fb94f165",
      "audio": ""
    },
    {
      "text": "A 3-year-old child with malnutrition is brought to a community health center by his mother. After a thorough examination, you decide to administer Vitamin A prophylaxis to help protect the child against potential childhood blindness. You recall that Vitamin A, once opened, has specific storage and usage guidelines. After opening a bottle of Vitamin A for prophylaxis, for how long can it be used without compromising its potency and safety?",
      "options": [
        {
          "label": "A",
          "text": "4 weeks",
          "correct": false
        },
        {
          "label": "B",
          "text": "8 weeks",
          "correct": true
        },
        {
          "label": "C",
          "text": "12 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "Till expiry date",
          "correct": false
        }
      ],
      "correct_answer": "B. 8 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. 8 weeks</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A Vitamin A bottle , once opened , should be used within 8 weeks . It is stored outside cold chain ( at room temperature )</li><li>\u27a4 Vitamin A bottle</li><li>\u27a4 once opened</li><li>\u27a4 8 weeks</li><li>\u27a4 stored</li><li>\u27a4 outside</li><li>\u27a4 at room temperature</li><li>\u27a4 Ref : Immunization handbook for health workers, 2018, MoHFW, GoI</li><li>\u27a4 Ref</li><li>\u27a4 : Immunization handbook for health workers, 2018, MoHFW, GoI</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d0dec4cf",
      "audio": ""
    },
    {
      "text": "During a training session on vaccine management and storage, the topic of the Open Vial Policy (OVP) is discussed. OVP permits the use of certain multi-dose vaccine vials in subsequent immunization sessions even after the vial has been opened, as long as specific conditions are met. This policy is crucial for efficient vaccine utilization, especially in resource-limited settings. The trainees are asked to identify which of the following vaccines is NOT included under the Open Vial Policy, meaning it should not be used in subsequent sessions once the vial has been opened.",
      "options": [
        {
          "label": "A",
          "text": "Pentavalent",
          "correct": false
        },
        {
          "label": "B",
          "text": "IPV",
          "correct": false
        },
        {
          "label": "C",
          "text": "JE",
          "correct": true
        },
        {
          "label": "D",
          "text": "OPV",
          "correct": false
        }
      ],
      "correct_answer": "C. JE",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) JE</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Open vial policy \u2013 for Hep B, OPV, DPT, pentavalent, TT, PCV, IPV, Rotavirus vaccines</li><li>\u27a4 Open vial policy</li><li>\u27a4 Hep B, OPV, DPT, pentavalent, TT, PCV, IPV, Rotavirus vaccines</li><li>\u27a4 No open vial policy for - BCG, MR, JE Vaccines</li><li>\u27a4 No open vial policy</li><li>\u27a4 BCG, MR, JE Vaccines</li><li>\u27a4 Ref: Immunization handbook for health workers, 2018, MoHFW, GoI, Pg, 67</li><li>\u27a4 Ref:</li><li>\u27a4 Immunization handbook for health workers, 2018, MoHFW, GoI, Pg, 67</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "51f10a9d",
      "audio": ""
    },
    {
      "text": "In a vaccine management training session for healthcare providers, the shake test is introduced as a technique to evaluate the viability of vaccines that might have been compromised due to freezing. The shake test is an important tool in determining whether a vaccine has been damaged by freezing and thus lost its potency. The attendees are asked to identify an accurate statement regarding the implementation and interpretation of the shake test in vaccine management.",
      "options": [
        {
          "label": "A",
          "text": "Shake Test is used to assess the heat damage to the vaccines",
          "correct": false
        },
        {
          "label": "B",
          "text": "If the sediments in the suspect vial settle more slowly, the suspect vaccine may be used.",
          "correct": true
        },
        {
          "label": "C",
          "text": "If the sediments in the suspect vial settle at the same rate, the suspect vaccine can be used.",
          "correct": false
        },
        {
          "label": "D",
          "text": "If the sediments in the suspect vial settle at the faster rate, the suspect vaccine can be used.",
          "correct": false
        }
      ],
      "correct_answer": "B. If the sediments in the suspect vial settle more slowly, the suspect vaccine may be used.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/24/image_5iW48Aq.png"
      ],
      "explanation": "<p><strong>Ans. B) If the sediments in the suspect vial settle more slowly, the suspect vaccine may be used.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 SHAKE TEST is used to check if freeze-sensitive vaccines have been damaged by exposure to freezing temperatures below 0 degrees C; after the test, the previously frozen vaccine shows flakes.</li><li>\u2022 SHAKE TEST</li><li>\u2022 if freeze-sensitive vaccines</li><li>\u2022 damaged by exposure</li><li>\u2022 freezing temperatures</li><li>\u2022 below 0 degrees</li><li>\u2022 C;</li><li>\u2022 the previously</li><li>\u2022 frozen vaccine</li><li>\u2022 shows flakes.</li><li>\u2022 Method of Shake test :</li><li>\u2022 Shake test</li><li>\u2022 Test Vial : Vial which is suspected to have been frozen Frozen control vial : Take a similar (as Test vial) vaccine vial with same manufacturer, batch number, antigen(s), Label it properly. Freeze it overnight at -20 degrees C, then let it haw (Do not heat). Hold the Test vial and Control vials between thumb and forefinger and shake them vigorously (10-15 seconds). Place both vials on even flat surface for 30 minutes observation, compare the sedimentation rates (SR).</li><li>\u2022 Test Vial : Vial which is suspected to have been frozen</li><li>\u2022 Test Vial</li><li>\u2022 suspected</li><li>\u2022 frozen</li><li>\u2022 Frozen control vial : Take a similar (as Test vial) vaccine vial with same manufacturer, batch number, antigen(s), Label it properly. Freeze it overnight at -20 degrees C, then let it haw (Do not heat).</li><li>\u2022 Frozen control vial</li><li>\u2022 similar</li><li>\u2022 vaccine vial</li><li>\u2022 same manufacturer, batch number, antigen(s), Label it properly.</li><li>\u2022 Freeze</li><li>\u2022 overnight</li><li>\u2022 -20</li><li>\u2022 then</li><li>\u2022 haw</li><li>\u2022 Hold the Test vial and Control vials between thumb and forefinger and shake them vigorously (10-15 seconds).</li><li>\u2022 Test vial and Control vials</li><li>\u2022 thumb and forefinger</li><li>\u2022 shake</li><li>\u2022 them vigorously</li><li>\u2022 Place both vials on even flat surface for 30 minutes observation, compare the sedimentation rates (SR).</li><li>\u2022 Place both vials</li><li>\u2022 flat surface</li><li>\u2022 30 minutes</li><li>\u2022 compare</li><li>\u2022 sedimentation rates (SR).</li><li>\u2022 Interpretation:</li><li>\u2022 If SR in Test vial < Control vial : Vaccine had not been damaged If SR in Test vial > Control vial : Vaccine had been damaged , do not use and inform the supervisors.</li><li>\u2022 If SR in Test vial < Control vial : Vaccine had not been damaged</li><li>\u2022 SR</li><li>\u2022 Test vial</li><li>\u2022 Control vial</li><li>\u2022 not</li><li>\u2022 damaged</li><li>\u2022 If SR in Test vial > Control vial : Vaccine had been damaged , do not use and inform the supervisors.</li><li>\u2022 SR</li><li>\u2022 Test vial > Control vial</li><li>\u2022 damaged</li><li>\u2022 do not use</li><li>\u2022 inform</li><li>\u2022 supervisors.</li><li>\u2022 Shake Test is used to assess the freeze damage to Aluminium based freeze sensitive vaccines such as DPT, TT, Td etc.</li><li>\u2022 Shake Test</li><li>\u2022 freeze damage to Aluminium</li><li>\u2022 freeze sensitive</li><li>\u2022 DPT, TT, Td</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Shake test is used to check if freeze-sensitive vaccines have been damaged by exposure to freezing temperatures below 0 degrees C; After the test, the previously Frozen vaccine shows flakes . If the Sedimentation rate of Test / suspect vial is more than Control vial , means the Vaccine had been damaged.</li><li>\u27a4 Shake test</li><li>\u27a4 freeze-sensitive vaccines</li><li>\u27a4 damaged</li><li>\u27a4 freezing temperatures below 0</li><li>\u27a4 previously Frozen vaccine</li><li>\u27a4 shows flakes</li><li>\u27a4 Sedimentation rate</li><li>\u27a4 Test</li><li>\u27a4 suspect vial</li><li>\u27a4 more than Control vial</li><li>\u27a4 had been damaged.</li><li>\u27a4 Shake Test is used to assess the freeze damage to Aluminium based freeze sensitive vaccines such as DPT, TT, Td etc .</li><li>\u27a4 Shake Test</li><li>\u27a4 used to assess</li><li>\u27a4 damage to Aluminium based freeze sensitive vaccines</li><li>\u27a4 DPT, TT, Td</li><li>\u27a4 .</li><li>\u27a4 Ref : Park 27/e p123</li><li>\u27a4 Ref</li><li>\u27a4 : Park 27/e p123</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "225b9a66",
      "audio": ""
    },
    {
      "text": "As part of a training session for new healthcare staff, you are emphasizing the critical aspect of vaccine storage and the significance of monitoring the condition of vaccine vials. An essential tool in this process is the Vaccine Vial Monitor (VVM). It's crucial for the staff to understand the function and importance of the VVM in ensuring vaccine potency. Which of the following statements accurately reflects the true purpose or function of the Vaccine Vial Monitor?",
      "options": [
        {
          "label": "A",
          "text": "The VVM number indicates the time in days that it takes for the inner square to reach the color indicating a discard point, if the vial is exposed to a constant temperature of 37-degree C.",
          "correct": false
        },
        {
          "label": "B",
          "text": "VVM is the marker of the cold chain maintenance and the potency of the vaccine",
          "correct": false
        },
        {
          "label": "C",
          "text": "The inner square is white and the outer circle is blue",
          "correct": false
        },
        {
          "label": "D",
          "text": "All the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All the above",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/10/image-20230710180846-1.png"
      ],
      "explanation": "<p><strong>Ans. D) All the above</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 VVM is a marker of potency .</li><li>\u2022 VVM</li><li>\u2022 potency</li><li>\u2022 VVM indicates efficiency of cold chain (temperature maintenance)</li><li>\u2022 VVM</li><li>\u2022 efficiency</li><li>\u2022 cold chain</li><li>\u2022 VVM is a simple tool that enables vaccinator to know if the vaccine is potent at the time of administration .</li><li>\u2022 VVM</li><li>\u2022 enables vaccinator</li><li>\u2022 vaccine is potent</li><li>\u2022 administration</li><li>\u2022 VVM is a label containing a heat-sensitive material which is placed on a vaccine vial to register cumulative heat exposure over time . If the color of inner square is similar or darker than the outer circle , the vaccine vial should be discarded. (Only inner square changes colour , circle always remain blue )</li><li>\u2022 VVM</li><li>\u2022 heat-sensitive</li><li>\u2022 vaccine vial</li><li>\u2022 register</li><li>\u2022 heat exposure</li><li>\u2022 over time</li><li>\u2022 color</li><li>\u2022 inner square</li><li>\u2022 similar or darker</li><li>\u2022 outer circle</li><li>\u2022 vial</li><li>\u2022 discarded.</li><li>\u2022 inner square changes colour</li><li>\u2022 circle</li><li>\u2022 blue</li><li>\u2022 Mandatory since 1998 for quality assurance. This is an example of \" Appropriate Technology \".</li><li>\u2022 Mandatory</li><li>\u2022 1998</li><li>\u2022 Appropriate Technology</li><li>\u2022 WHO Grading of VVM (OPV) -</li><li>\u2022 WHO</li><li>\u2022 VVM (OPV)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The purpose of the Vaccine Vial Monitor (VVM), which is to indicate a vaccine's exposure to heat and help in determining its viability based on cumulative heat exposure , rather than freezing conditions, expiration dates, or tampering .</li><li>\u27a4 Vaccine Vial Monitor (VVM),</li><li>\u27a4 indicate a vaccine's</li><li>\u27a4 heat</li><li>\u27a4 its viability</li><li>\u27a4 heat exposure</li><li>\u27a4 rather</li><li>\u27a4 freezing conditions, expiration dates,</li><li>\u27a4 tampering</li><li>\u27a4 Ref: Park 26 th ed pg 121, https://www.who.int/publications/m/item/vaccine-vial-</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 121, https://www.who.int/publications/m/item/vaccine-vial-</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0bdc1791",
      "audio": ""
    },
    {
      "text": "In a workshop dedicated to vaccine storage and handling, the topic of the \"shake test\" is introduced. This test is a practical method used to determine if freeze-sensitive vaccines have been damaged due to freezing. The participants are presented with a list of vaccines and asked to identify for which vaccine the shake test is not applicable. This question aims to assess their understanding of the shake test and its relevance to different types of vaccines, especially in the context of freeze sensitivity.",
      "options": [
        {
          "label": "A",
          "text": "DPT",
          "correct": false
        },
        {
          "label": "B",
          "text": "IPV",
          "correct": true
        },
        {
          "label": "C",
          "text": "Hepatitis B",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tetanus Toxoid",
          "correct": false
        }
      ],
      "correct_answer": "B. IPV",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/24/image_dfA9vwc.png"
      ],
      "explanation": "<p><strong>Ans. B) IPV</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Shake Test is not applicable for IPV.</li><li>\u2022 Shake Test</li><li>\u2022 not</li><li>\u2022 IPV.</li><li>\u2022 The Shake Test currently applies to freeze sensitive vaccines which are:</li><li>\u2022 Shake Test</li><li>\u2022 freeze sensitive vaccines</li><li>\u2022 DPT-Hep B-Hib TT PCV13 Hepatitis B HPV</li><li>\u2022 DPT-Hep B-Hib</li><li>\u2022 TT</li><li>\u2022 PCV13</li><li>\u2022 Hepatitis B</li><li>\u2022 HPV</li><li>\u2022 SHAKE TEST</li><li>\u2022 SHAKE TEST</li><li>\u2022 It is used to check if Freeze sensitive vaccines have been damaged by exposure to freezing temperatures below 0 degrees C ; after the test the previously Frozen vaccine shows flakes</li><li>\u2022 used</li><li>\u2022 Freeze sensitive vaccines</li><li>\u2022 damaged by exposure</li><li>\u2022 freezing temperatures</li><li>\u2022 below 0 degrees</li><li>\u2022 C</li><li>\u2022 previously Frozen vaccine</li><li>\u2022 flakes</li><li>\u2022 Interpretation:</li><li>\u2022 Interpretation:</li><li>\u2022 If SR in Test vial < Control vial: Vaccine had not been damaged If SR in Test vial > Control vial : Vaccine had been damaged , Do not use and Inform the supervisors</li><li>\u2022 If SR in Test vial < Control vial: Vaccine had not been damaged</li><li>\u2022 SR</li><li>\u2022 Test vial < Control vial:</li><li>\u2022 not</li><li>\u2022 damaged</li><li>\u2022 If SR in Test vial > Control vial : Vaccine had been damaged , Do not use and Inform the supervisors</li><li>\u2022 SR</li><li>\u2022 Test vial > Control vial</li><li>\u2022 damaged</li><li>\u2022 Do not use</li><li>\u2022 Inform</li><li>\u2022 supervisors</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Shake Test currently applies to freeze sensitive vaccines which are: DPT-Hep B-Hib; TT; PCV13; Hepatitis B; HPV . Shake Test is not applicable for IPV</li><li>\u27a4 Shake Test</li><li>\u27a4 freeze sensitive vaccines</li><li>\u27a4 DPT-Hep B-Hib; TT; PCV13; Hepatitis B; HPV</li><li>\u27a4 Shake Test</li><li>\u27a4 not</li><li>\u27a4 IPV</li><li>\u27a4 Ref: Park 27/e p123</li><li>\u27a4 Ref:</li><li>\u27a4 Park 27/e p123</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a6913b48",
      "audio": ""
    },
    {
      "text": "A pediatrician is overseeing the reception of a new shipment of vaccines at her clinic. During the inspection, she notices that one of the boxes, which contains a vaccine sensitive to light, was inadvertently placed near a window where it was exposed to direct sunlight. Understanding the importance of protecting vaccines from light to maintain their efficacy, she acts swiftly to identify and safeguard the affected vaccine. Among the vaccines in her shipment, which one is most likely to be adversely affected by exposure to sunlight?",
      "options": [
        {
          "label": "A",
          "text": "Measles Rubella vaccine",
          "correct": true
        },
        {
          "label": "B",
          "text": "Tetanus toxoid",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hepatitis B",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rabies Vaccine",
          "correct": false
        }
      ],
      "correct_answer": "A. Measles Rubella vaccine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) Measles Rubella vaccine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B .TT, Option C. Hep B and Option D. Rabies vaccine - While all vaccines should be stored according to manufacturer guidelines to ensure their efficacy, but these are supplied in transparent glass vial , and are not light sensitive.</li><li>\u2022 Option B .TT, Option C. Hep B and Option D. Rabies vaccine -</li><li>\u2022 stored according</li><li>\u2022 manufacturer guidelines</li><li>\u2022 ensure</li><li>\u2022 efficacy,</li><li>\u2022 but</li><li>\u2022 transparent glass vial</li><li>\u2022 not</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Vaccines sensitive to light are : BCG, Measles, MR, MMR, MMRV, and Rubella.</li><li>\u27a4 Vaccines sensitive</li><li>\u27a4 light</li><li>\u27a4 : BCG, Measles, MR, MMR, MMRV, and Rubella.</li><li>\u27a4 Ref: Park 26 th ed pg 117</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 117</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "dfe41b09",
      "audio": ""
    },
    {
      "text": "As an intern at a community health clinic, you're being quizzed by your supervising Resident on vaccine storage practices. The Resident presents several statements about how vaccines should be stored and asks you to identify the incorrect one. Proper storage is crucial for vaccine efficacy, and this test is designed to assess your understanding of the best practices in vaccine storage. Which of the following statements about vaccine storage is NOT true?",
      "options": [
        {
          "label": "A",
          "text": "Inside ILR, freeze sensitive vaccines should be kept at the bottom of the basket",
          "correct": true
        },
        {
          "label": "B",
          "text": "Inside ILR, Heat sensitive vaccines should be kept at the bottom of the basket",
          "correct": false
        },
        {
          "label": "C",
          "text": "The temperature inside the ILRs are kept between +2 to +8 degree C.",
          "correct": false
        },
        {
          "label": "D",
          "text": "ILRs require minimum 8 hours of electricity per day.",
          "correct": false
        }
      ],
      "correct_answer": "A. Inside ILR, freeze sensitive vaccines should be kept at the bottom of the basket",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/11/image-20230711110142-1.png"
      ],
      "explanation": "<p><strong>Ans. A) Inside ILR, freeze sensitive vaccines should be kept at the bottom of the basket</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Options are correct :-</li><li>\u2022 Options</li><li>\u2022 correct</li><li>\u2022 Heat sensitive vaccines in the bottom of the basket .</li><li>\u2022 Heat sensitive vaccines</li><li>\u2022 bottom of the basket</li><li>\u2022 An ILR is an ice-lined refrigerator which is used to store vaccines at PHC and CHC . The temperature at which the vaccines are kept is +2 to +8 degree Celsius . At this temperature range, the vaccines can be stored for 1 month in both PHC and CHC.</li><li>\u2022 ILR</li><li>\u2022 ice-lined refrigerator</li><li>\u2022 PHC</li><li>\u2022 CHC</li><li>\u2022 temperature</li><li>\u2022 vaccines</li><li>\u2022 kept</li><li>\u2022 +2 to +8 degree Celsius</li><li>\u2022 stored for 1 month</li><li>\u2022 PHC and CHC.</li><li>\u2022 It requires minimum 8 hours of electricity per day and it can store vaccines for around 5 days without electricity .</li><li>\u2022 minimum 8 hours of electricity per day</li><li>\u2022 can store</li><li>\u2022 5 days without electricity</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Freeze-sensitive vaccines at the top of the basket and Heat sensitive vaccines in the bottom of the basket.</li><li>\u27a4 Freeze-sensitive vaccines</li><li>\u27a4 top</li><li>\u27a4 basket</li><li>\u27a4 Heat sensitive vaccines</li><li>\u27a4 bottom</li><li>\u27a4 basket.</li><li>\u27a4 Ref: Immunization handbook for health workers, 2018, MoHFW, GoI, pg 73</li><li>\u27a4 Ref:</li><li>\u27a4 Immunization handbook for health workers, 2018, MoHFW, GoI, pg 73</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4b5ddaab",
      "audio": ""
    },
    {
      "text": "In a Primary Health Care (PHC) setting, you are approached by a pharmacist who has encountered a problem: the Ice Lined Refrigerator (ILR) malfunctioned, resulting in the freezing of the DPT (Diphtheria, Pertussis, Tetanus) vaccine. The pharmacist is seeking your advice on the appropriate course of action for the frozen vaccine. Handling such situations correctly is crucial to ensure vaccine safety and efficacy. What should be done with the DPT vaccine that has been frozen due to the ILR malfunction?",
      "options": [
        {
          "label": "A",
          "text": "Shaken thoroughly before use",
          "correct": false
        },
        {
          "label": "B",
          "text": "Brought to +2 to +8 degree temperature before use",
          "correct": false
        },
        {
          "label": "C",
          "text": "Discarded the vial",
          "correct": true
        },
        {
          "label": "D",
          "text": "Allowed to melt before use",
          "correct": false
        }
      ],
      "correct_answer": "C. Discarded the vial",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Discarded the vial.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 DPT vaccine is sensitive to freezing , and freezing can alter its properties, making it ineffective or unsafe . The appropriate action is to discard any DPT vaccine that has been frozen.</li><li>\u2022 DPT vaccine</li><li>\u2022 sensitive</li><li>\u2022 freezing</li><li>\u2022 alter its properties,</li><li>\u2022 ineffective or unsafe</li><li>\u2022 discard any DPT vaccine</li><li>\u2022 been frozen.</li><li>\u2022 Shake test -</li><li>\u2022 Shake test -</li><li>\u2022 The Shake Test need not be conducted under the following circumstances - When solid frozen vaccine vial(s) have been found.</li><li>\u2022 Shake Test</li><li>\u2022 not</li><li>\u2022 solid frozen vaccine vial(s)</li><li>\u2022 Shake Test is used to assess the freeze damage to Aluminum based freeze sensitive vaccines such as DPT, TT, Td etc. If the sediments in the suspect vial settle more slowly , the suspect vaccine may be used.</li><li>\u2022 Shake Test</li><li>\u2022 freeze damage to Aluminum</li><li>\u2022 freeze sensitive vaccines</li><li>\u2022 DPT, TT, Td</li><li>\u2022 sediments</li><li>\u2022 suspect vial settle more slowly</li><li>\u2022 suspect vaccine</li><li>\u2022 used.</li><li>\u2022 The Shake Test currently applies to freeze sensitive vaccines which are:</li><li>\u2022 Shake Test</li><li>\u2022 freeze sensitive vaccines</li><li>\u2022 DPT-Hep B-Hib TT PCV13 Hepatitis B HPV</li><li>\u2022 DPT-Hep B-Hib</li><li>\u2022 TT</li><li>\u2022 PCV13</li><li>\u2022 Hepatitis B</li><li>\u2022 HPV</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Shake Test is used to assess the freeze damage to Aluminum based freeze sensitive vaccines such as DPT, TT, Td etc. If the sediments in the suspect vial settle more slowly , the suspect vaccine may be used</li><li>\u27a4 Shake Test</li><li>\u27a4 freeze damage</li><li>\u27a4 Aluminum based freeze</li><li>\u27a4 sensitive vaccines</li><li>\u27a4 DPT, TT, Td</li><li>\u27a4 sediments</li><li>\u27a4 suspect vial</li><li>\u27a4 settle more slowly</li><li>\u27a4 suspect vaccine</li><li>\u27a4 used</li><li>\u27a4 DPT vaccine is sensitive to freezing . The appropriate action is to discard any DPT vaccine that has been frozen.</li><li>\u27a4 DPT vaccine</li><li>\u27a4 sensitive to freezing</li><li>\u27a4 discard any</li><li>\u27a4 DPT vaccine</li><li>\u27a4 been frozen.</li><li>\u27a4 Ref: Park 27/e p123</li><li>\u27a4 Ref:</li><li>\u27a4 Park 27/e p123</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "77eee662",
      "audio": ""
    },
    {
      "text": "A nurse in a rural community health clinic is tasked with storing a new shipment of the Oral Polio Vaccine (OPV). She is aware that OPV requires specific storage conditions to maintain its efficacy, particularly in terms of temperature. In order to correctly store the OPV, she needs to ensure that the deep freezer is set to the appropriate temperature range. What is the correct temperature range that the nurse should maintain in the deep freezer for the optimal storage of the Oral Polio Vaccine?",
      "options": [
        {
          "label": "A",
          "text": "+ 2 degree C to + 8 degree C",
          "correct": false
        },
        {
          "label": "B",
          "text": "\u2013 2 degree C to \u2013 8 degree C",
          "correct": false
        },
        {
          "label": "C",
          "text": "\u2013 15 degree C to \u2013 25 degree C",
          "correct": true
        },
        {
          "label": "D",
          "text": "\u2013 8 degree C to \u2013 10 degree C",
          "correct": false
        }
      ],
      "correct_answer": "C. \u2013 15 degree C to \u2013 25 degree C",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-160928.jpg"
      ],
      "explanation": "<p><strong>Ans. C) \u2013 15 degree C to \u2013 25 degreeC</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The cabinet temperature of the deep freezer is maintained between \u2013 15 degree C to \u2013 25 degree C .</li><li>\u2022 cabinet temperature</li><li>\u2022 deep freezer</li><li>\u2022 \u2013 15 degree C to \u2013 25 degree C</li><li>\u2022 Ice packs are prepared by keeping them in a Deep freezer.</li><li>\u2022 Ice packs</li><li>\u2022 Deep freezer.</li><li>\u2022 All vaccines are stored at a temperature of +2\u00b0 to +8\u00b0C including OPV (OPV vaccine is stored at -15\u00b0 to -25\u00b0C , i.e., Subzero/freezing temperatures only for long-term storage i.e. >1 month ) and YF vaccine is stored at -30\u00b0 to +5\u00b0C.</li><li>\u2022 All vaccines</li><li>\u2022 stored</li><li>\u2022 temperature</li><li>\u2022 +2\u00b0 to +8\u00b0C</li><li>\u2022 OPV</li><li>\u2022 stored</li><li>\u2022 -15\u00b0 to -25\u00b0C</li><li>\u2022 Subzero/freezing</li><li>\u2022 long-term storage</li><li>\u2022 >1 month</li><li>\u2022 YF vaccine</li><li>\u2022 -30\u00b0 to +5\u00b0C.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cold chain components (equipments) and levels in India:</li><li>\u27a4 Cold chain components (equipments) and levels in India:</li><li>\u27a4 Ref: Park 26 th ed pg118</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg118</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "372014e4",
      "audio": ""
    },
    {
      "text": "In a vaccination drive, a community health officer is tasked with estimating the necessary quantity of vaccines, including a provision for potential wastage. Effective vaccine management requires accurate estimation to ensure sufficient supply without excessive waste. This estimation is particularly important for vaccines like MR (Measles-Rubella) and JE (Japanese Encephalitis), which have specific wastage factors. What is the permissible wastage factor for the MR and JE vaccines?",
      "options": [
        {
          "label": "A",
          "text": "1.11",
          "correct": false
        },
        {
          "label": "B",
          "text": "1.33",
          "correct": true
        },
        {
          "label": "C",
          "text": "1.5",
          "correct": false
        },
        {
          "label": "D",
          "text": "2",
          "correct": false
        }
      ],
      "correct_answer": "B. 1.33",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-180130.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/26/screenshot-2024-07-26-121458.png"
      ],
      "explanation": "<p><strong>Ans. B) 1.33</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. 1.11: Wastage factor for most of the vaccines except - BCG, MR, JE and RVV</li><li>\u2022 Option A. 1.11:</li><li>\u2022 Wastage factor</li><li>\u2022 except - BCG, MR, JE and RVV</li><li>\u2022 Option C. 1.5: Not applicable</li><li>\u2022 Option C. 1.5:</li><li>\u2022 Not applicable</li><li>\u2022 Option D. 2.0 - Wastage factor for BCG vaccine</li><li>\u2022 Option D. 2.0</li><li>\u2022 Wastage factor</li><li>\u2022 BCG vaccine</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Vaccine wastage rate and factor (for vaccine under UIP) -</li><li>\u27a4 Vaccine wastage rate and factor (for vaccine under UIP) -</li><li>\u27a4 Ref: Immunization handbook for health workers, 2018, MoHFW, GoI, pg 58.</li><li>\u27a4 Ref:</li><li>\u27a4 Immunization handbook for health workers, 2018, MoHFW, GoI, pg 58.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b4f64c4c",
      "audio": ""
    },
    {
      "text": "In a training session dedicated to understanding Adverse Events Following Immunization (AEFI), a medical intern is learning about the different categories and causes of AEFIs. One specific category is highlighted: an AEFI that occurs as a direct result of the inherent properties of the vaccine itself, rather than due to an error in vaccine administration or external factors. The intern is asked to identify the term used to describe this specific type of AEFI. What is this category of AEFI called?",
      "options": [
        {
          "label": "A",
          "text": "Vaccine quality defect-related reaction",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vaccine product related",
          "correct": true
        },
        {
          "label": "C",
          "text": "Immunization error",
          "correct": false
        },
        {
          "label": "D",
          "text": "Coincidental error",
          "correct": false
        }
      ],
      "correct_answer": "B. Vaccine product related",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Vaccine product related</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Vaccine quality defect-related reaction- An AEFI that is caused or precipitated by a vaccine that is due to one or more quality defects of the vaccine product , including its administration device as provided by the manufacturer.</li><li>\u2022 Option A. Vaccine quality defect-related reaction-</li><li>\u2022 AEFI</li><li>\u2022 caused or</li><li>\u2022 precipitated</li><li>\u2022 vaccine</li><li>\u2022 due</li><li>\u2022 one or more quality defects</li><li>\u2022 vaccine product</li><li>\u2022 its administration</li><li>\u2022 device</li><li>\u2022 manufacturer.</li><li>\u2022 Option C. Immunization error: (formerly \u201cprogram error\u201d) An AEFI that is caused by inappropriate vaccine handling , prescribing or administration and thus by its nature is preventable.</li><li>\u2022 Option C. Immunization error:</li><li>\u2022 AEFI</li><li>\u2022 inappropriate vaccine handling</li><li>\u2022 prescribing or administration</li><li>\u2022 its nature</li><li>\u2022 preventable.</li><li>\u2022 Immunization anxiety-related reaction (formerly \u201cinjection reaction\u201d) An AEFI arising from anxiety about the immunization.</li><li>\u2022 Immunization anxiety-related reaction</li><li>\u2022 AEFI arising</li><li>\u2022 anxiety</li><li>\u2022 Option D. Coincidental event: An AEFI that is caused by something other than the vaccine product, immunization error or immunization anxiety .</li><li>\u2022 Option D. Coincidental event:</li><li>\u2022 AEFI</li><li>\u2022 other than</li><li>\u2022 vaccine product, immunization error or immunization anxiety</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Vaccine product-related AEFI includes adverse events that occur due to the inherent properties of the vaccine itself , while Programmatic error occurs due to errors in vaccine administration, handling, storage, or other programmatic issues , Vaccine quality defect-related are due to some defect in the vaccine's quality, like contamination or improper storage and Coincidental event happens to occur after vaccination but is not causally related to the vaccination itself.</li><li>\u27a4 Vaccine product-related AEFI</li><li>\u27a4 adverse</li><li>\u27a4 inherent properties of the vaccine itself</li><li>\u27a4 Programmatic error</li><li>\u27a4 due to errors</li><li>\u27a4 vaccine administration, handling, storage,</li><li>\u27a4 other programmatic</li><li>\u27a4 issues</li><li>\u27a4 Vaccine quality</li><li>\u27a4 some defect</li><li>\u27a4 contamination or improper storage</li><li>\u27a4 Coincidental</li><li>\u27a4 not</li><li>\u27a4 vaccination itself.</li><li>\u27a4 Ref: Park 26 th ed pg 123</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 123</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a69a6f5e",
      "audio": ""
    },
    {
      "text": "In the process of reviewing a poster you created for a Community health talk on vaccine safety, a Senior resident quizzes you about the content, particularly focusing on your list of serious vaccine reactions. He asks you to identify which of the reactions listed on your poster is NOT typically considered a serious adverse event following vaccination. It's crucial to accurately distinguish between serious and non-serious adverse events to provide correct information to the public. Which of the following reactions, as mentioned on your poster, would not be classified as a serious adverse event following vaccination?",
      "options": [
        {
          "label": "A",
          "text": "\u200b\u200b\u200b\u200bThat leads to death",
          "correct": false
        },
        {
          "label": "B",
          "text": "Seizures (Non hospitalized)",
          "correct": true
        },
        {
          "label": "C",
          "text": "Leading to disability",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cluster of cases",
          "correct": false
        }
      ],
      "correct_answer": "B. Seizures (Non hospitalized)",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-161320.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-162235.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Seizures (Non hospitalized)</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 AEFIs that are not minor but do not result in death , hospitalization or disability are categorized as severe. Examples include non-hospitalized cases of seizures, hypotonic hyporesponsive episodes (HHEs), persistent screaming, severe local reaction, injection site abscesses, intussusception , etc.</li><li>\u2022 AEFIs</li><li>\u2022 not</li><li>\u2022 do not</li><li>\u2022 death</li><li>\u2022 hospitalization or disability</li><li>\u2022 categorized</li><li>\u2022 severe.</li><li>\u2022 non-hospitalized cases</li><li>\u2022 seizures, hypotonic hyporesponsive episodes (HHEs),</li><li>\u2022 screaming,</li><li>\u2022 severe local reaction, injection site abscesses, intussusception</li><li>\u2022 An AEFI will be considered serious if it results in death (option a) , requires hospitalization , results in persistent or significant disability (option C) /incapacity or a cluster (two or more cases) (option D) of AEFIs occur in a geographical area.</li><li>\u2022 An AEFI</li><li>\u2022 considered serious</li><li>\u2022 death (option a)</li><li>\u2022 hospitalization</li><li>\u2022 persistent or significant disability (option C)</li><li>\u2022 cluster (two or more cases)</li><li>\u2022 (option D)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Adverse effects following immunization (AEFI):</li><li>\u27a4 Minor Vaccine Reactions:</li><li>\u27a4 Minor Vaccine Reactions:</li><li>\u27a4 Minor Vaccine Reactions:</li><li>\u27a4 Rare vaccine reactions:</li><li>\u27a4 Rare vaccine reactions:</li><li>\u27a4 Ref : Immunization handbook for health workers, 2018, MoHFW, GoI, pg 109, Park 27/e p245</li><li>\u27a4 Ref</li><li>\u27a4 : Immunization handbook for health workers, 2018, MoHFW, GoI, pg 109, Park 27/e p245</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7a1f6781",
      "audio": ""
    },
    {
      "text": "In a neurology rotation, medical students delve into the various causes of Guillain-Barre syndrome (GBS), a rare neurological disorder. One particular area of interest is the potential association of GBS with vaccines. While the occurrence is rare, there has been evidence linking certain vaccines to the development of GBS. The students are asked to identify which of the following vaccines has been associated, albeit infrequently, with the development of Guillain-Barre syndrome.",
      "options": [
        {
          "label": "A",
          "text": "\u200b\u200b\u200bOPV",
          "correct": false
        },
        {
          "label": "B",
          "text": "Influenza",
          "correct": true
        },
        {
          "label": "C",
          "text": "Measles",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tetanus toxoid",
          "correct": false
        }
      ],
      "correct_answer": "B. Influenza",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-182142.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-180930_gt0vF4z.jpg"
      ],
      "explanation": "<p><strong>Ans. B) Influenza</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. OPV: Rare vaccine reaction - Vaccine-associated paralytic Poliomyelitis (VAPP).</li><li>\u2022 Option A. OPV:</li><li>\u2022 Rare</li><li>\u2022 reaction</li><li>\u2022 Vaccine-associated paralytic</li><li>\u2022 Poliomyelitis</li><li>\u2022 Option C. Measles/ MMR: Rare vaccine reaction - Febrile seizures, Thrombocytopenia, Anaphylaxis, Encephalopathy.</li><li>\u2022 Option C. Measles/ MMR:</li><li>\u2022 Rare</li><li>\u2022 Febrile seizures,</li><li>\u2022 Thrombocytopenia, Anaphylaxis, Encephalopathy.</li><li>\u2022 Option D. TT: Rare vaccine reaction - Brachial neuritis, Anaphylaxis</li><li>\u2022 Option D. TT:</li><li>\u2022 Rare</li><li>\u2022 Brachial neuritis, Anaphylaxis</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Rare vaccine reactions:</li><li>\u27a4 Rare vaccine reactions:</li><li>\u27a4 AEFI and Vaccines -</li><li>\u27a4 AEFI and Vaccines -</li><li>\u27a4 Ref: Park 27 th ed pg 245</li><li>\u27a4 Ref:</li><li>\u27a4 Park 27 th ed pg 245</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d1b90367",
      "audio": ""
    },
    {
      "text": "In a pediatric review meeting, healthcare professionals are discussing various adverse reactions following vaccinations. A key point of discussion is the association of certain vaccines with thrombocytopenia, a condition characterized by an abnormally low number of platelets. One resident queries about a specific vaccine that has a known association with thrombocytopenia as a potential adverse reaction. Among the following, which vaccine is recognized for its linkage with thrombocytopenia?",
      "options": [
        {
          "label": "A",
          "text": "BCG",
          "correct": false
        },
        {
          "label": "B",
          "text": "JE",
          "correct": false
        },
        {
          "label": "C",
          "text": "MMR",
          "correct": true
        },
        {
          "label": "D",
          "text": "IPV",
          "correct": false
        }
      ],
      "correct_answer": "C. MMR",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-180930_PCGedPz.jpg"
      ],
      "explanation": "<p><strong>Ans. C) MMR</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. BCG : AEFI (rare)- Suppurative lymphadenitis, BCG osteitis, Disseminated BCGiosis</li><li>\u2022 Option A. BCG : AEFI (rare)-</li><li>\u2022 Option B. JE: AEFI - Enchephalitis, encephalopathy</li><li>\u2022 Option B. JE: AEFI -</li><li>\u2022 Option D. IPV : AEFI - Febrile convulsions</li><li>\u2022 Option D. IPV : AEFI -</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Vaccine and AEFI -</li><li>\u27a4 Vaccine and AEFI -</li><li>\u27a4 Ref: Park 27 th ed pg 245</li><li>\u27a4 Ref:</li><li>\u27a4 Park 27 th ed pg 245</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f740c683",
      "audio": ""
    },
    {
      "text": "In a study of the effectiveness of the Diphtheria vaccine in preventing Diphtheria, the following data were collected by studying the children who had the disease. What was the protective efficacy of the Diphtheria vaccine?",
      "options": [
        {
          "label": "A",
          "text": "50%",
          "correct": false
        },
        {
          "label": "B",
          "text": "40%",
          "correct": false
        },
        {
          "label": "C",
          "text": "90%",
          "correct": false
        },
        {
          "label": "D",
          "text": "75%",
          "correct": true
        }
      ],
      "correct_answer": "D. 75%",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-164538.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/24/image.png"
      ],
      "explanation": "<p><strong>Ans. D) 75%</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The efficacy of vaccine , or the percentage reduction in the incidence of disease in vaccinated compared with unvaccinated subjects , is given by the expression.</li><li>\u2022 efficacy of vaccine</li><li>\u2022 percentage</li><li>\u2022 reduction</li><li>\u2022 incidence of disease</li><li>\u2022 vaccinated</li><li>\u2022 unvaccinated subjects</li><li>\u2022 Attack rate in vaccinated = 400/4000 = 0.1</li><li>\u2022 Attack rate</li><li>\u2022 vaccinated</li><li>\u2022 0.1</li><li>\u2022 Attack rate in Unvaccinated = 400/1000 = 0.4</li><li>\u2022 Attack rate</li><li>\u2022 Unvaccinated</li><li>\u2022 0.4</li><li>\u2022 VE = 1 - (0.1/0.4) *100 = 75%</li><li>\u2022 VE = 1 - (0.1/0.4)</li><li>\u2022 *100</li><li>\u2022 NOTE -</li><li>\u2022 NOTE</li><li>\u2022 Measles vaccine efficacy with single dose: 90% OPV vaccine efficacy with single dose: 65-80% BCG vaccine efficacy with single dose : 50% TT vaccine efficacy with single dose: 70% Rubella vaccine efficacy with single dose : 95% (HIGHEST)</li><li>\u2022 Measles vaccine efficacy with single dose: 90%</li><li>\u2022 Measles vaccine efficacy</li><li>\u2022 single dose: 90%</li><li>\u2022 OPV vaccine efficacy with single dose: 65-80%</li><li>\u2022 OPV</li><li>\u2022 efficacy</li><li>\u2022 single dose: 65-80%</li><li>\u2022 BCG vaccine efficacy with single dose : 50%</li><li>\u2022 BCG</li><li>\u2022 efficacy</li><li>\u2022 single dose</li><li>\u2022 50%</li><li>\u2022 TT vaccine efficacy with single dose: 70%</li><li>\u2022 TT vaccine</li><li>\u2022 single dose: 70%</li><li>\u2022 Rubella vaccine efficacy with single dose : 95% (HIGHEST)</li><li>\u2022 Rubella vaccine efficacy</li><li>\u2022 single dose</li><li>\u2022 95% (HIGHEST)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Vaccine efficacy or vaccine effectiveness is the percentage reduction of disease cases in a vaccinated group of people compared to an unvaccinated group.</li><li>\u27a4 Vaccine efficacy</li><li>\u27a4 vaccine effectiveness</li><li>\u27a4 percentage reduction</li><li>\u27a4 disease</li><li>\u27a4 vaccinated group</li><li>\u27a4 compared</li><li>\u27a4 unvaccinated group.</li><li>\u27a4 Ref: Leon gordis 5 th ed.</li><li>\u27a4 Ref:</li><li>\u27a4 Leon gordis 5 th ed.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5ad2f734",
      "audio": ""
    },
    {
      "text": "A 6-year-old child is brought to the emergency room after sustaining a scratch on her right hand while playing with a cat at home. The examination reveals a single scratch mark without any active bleeding. In such a scenario, determining the most appropriate medical intervention is crucial to prevent any potential complications. What should be the most appropriate intervention for this child at this time?",
      "options": [
        {
          "label": "A",
          "text": "Reassure the parents that there is no risk of rabies as it is a pet animal and give wound care",
          "correct": false
        },
        {
          "label": "B",
          "text": "Reassure the parents that there is no risk of rabies as it is a pet animal and give wound care",
          "correct": false
        },
        {
          "label": "C",
          "text": "Administer rabies immunoglobulin (RIG) along with wound care",
          "correct": false
        },
        {
          "label": "D",
          "text": "Administer rabies vaccine along with wound care",
          "correct": true
        }
      ],
      "correct_answer": "D. Administer rabies vaccine along with wound care",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-162956.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Administer rabies vaccine along with wound care.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Category II situation - PEP is Immediate vaccination and Local treatment of wound</li><li>\u2022 Category II situation</li><li>\u2022 PEP</li><li>\u2022 Immediate vaccination</li><li>\u2022 Local treatment</li><li>\u2022 wound</li><li>\u2022 The components of post\u2013exposure prophylaxis are:</li><li>\u2022 components of post\u2013exposure prophylaxis</li><li>\u2022 Local treatment of wound Antibiotics and anti-tetanus measures Active immunization against rabies \u2013 if indicated Passive immunization with rabies immunoglobulin \u2013 if indicated Observe the animal for 10 days from the day of bite :</li><li>\u2022 Local treatment of wound</li><li>\u2022 Local treatment</li><li>\u2022 wound</li><li>\u2022 Antibiotics and anti-tetanus measures</li><li>\u2022 Antibiotics</li><li>\u2022 anti-tetanus measures</li><li>\u2022 Active immunization against rabies \u2013 if indicated</li><li>\u2022 Active immunization</li><li>\u2022 rabies</li><li>\u2022 Passive immunization with rabies immunoglobulin \u2013 if indicated</li><li>\u2022 Passive immunization</li><li>\u2022 rabies immunoglobulin</li><li>\u2022 Observe the animal for 10 days from the day of bite :</li><li>\u2022 animal for 10 days</li><li>\u2022 day of bite</li><li>\u2022 If healthy after 10 days : Discontinue post \u2013 exposure vaccination If dies within observation period : complete PEP If observation not possible: complete the post \u2013 exposure vaccination</li><li>\u2022 If healthy after 10 days : Discontinue post \u2013 exposure vaccination</li><li>\u2022 after 10 days</li><li>\u2022 post \u2013 exposure vaccination</li><li>\u2022 If dies within observation period : complete PEP</li><li>\u2022 dies</li><li>\u2022 observation period</li><li>\u2022 complete PEP</li><li>\u2022 If observation not possible: complete the post \u2013 exposure vaccination</li><li>\u2022 observation not</li><li>\u2022 complete</li><li>\u2022 post \u2013 exposure vaccination</li><li>\u2022 Local Treatment of Wound - Purpose of local treatment is to remove as much virus as possible, from site of inoculation, before it is absorbed on local nerve endings . Local wound treatment can reduce chances of Rabies by upto 80%.</li><li>\u2022 Local Treatment of Wound</li><li>\u2022 Purpose</li><li>\u2022 remove</li><li>\u2022 virus</li><li>\u2022 site of inoculation, before</li><li>\u2022 absorbed on local nerve endings</li><li>\u2022 Local wound treatment</li><li>\u2022 reduce</li><li>\u2022 Rabies</li><li>\u2022 upto 80%.</li><li>\u2022 Immediate flushing and washing wound area with plenty of soap and running water for minimum 15 minutes. Suturing: not recommended ; if necessary, do 24\u201348 hours later under cover of Anti-rabies serum (Local application with prior sensitivity testing) Chemical treatment with virucidal agents ( Alcohol, tincture, 0.01% aqueous iodine )</li><li>\u2022 Immediate flushing and washing wound area with plenty of soap and running water for minimum 15 minutes.</li><li>\u2022 Immediate flushing</li><li>\u2022 washing wound area</li><li>\u2022 plenty of soap</li><li>\u2022 running water</li><li>\u2022 minimum 15 minutes.</li><li>\u2022 Suturing: not recommended ; if necessary, do 24\u201348 hours later under cover of Anti-rabies serum (Local application with prior sensitivity testing)</li><li>\u2022 Suturing: not recommended</li><li>\u2022 24\u201348 hours later</li><li>\u2022 cover</li><li>\u2022 Anti-rabies serum</li><li>\u2022 Chemical treatment with virucidal agents ( Alcohol, tincture, 0.01% aqueous iodine )</li><li>\u2022 Chemical treatment</li><li>\u2022 virucidal agents</li><li>\u2022 Alcohol, tincture, 0.01% aqueous iodine</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Park 26 th ed 324</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed 324</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b1943ffe",
      "audio": ""
    },
    {
      "text": "In a prenatal consultation, a pregnant woman expresses concerns about the safety of receiving vaccinations during her pregnancy. It's crucial for healthcare providers to be aware of which vaccines are safe and which are contraindicated during pregnancy to ensure the health of both the mother and the developing fetus. The woman asks about specific vaccines and their safety in pregnancy. Which of the following vaccines is CONTRAINDICATED for pregnant women?",
      "options": [
        {
          "label": "A",
          "text": "Rabies vaccine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hepatitis B vaccine",
          "correct": false
        },
        {
          "label": "C",
          "text": "MR vaccine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Tetanus toxoid",
          "correct": false
        }
      ],
      "correct_answer": "C. MR vaccine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) MR vaccine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Rabies, Option B. Hep B and Option D. TT - can be given during Pregnancy .</li><li>\u2022 Option A. Rabies, Option B. Hep B and Option D. TT</li><li>\u2022 given</li><li>\u2022 Pregnancy .</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Vaccines contraindicated in Pregnancy - All live vaccines except Yellow fever vaccine.</li><li>\u2022 Vaccines contraindicated</li><li>\u2022 Pregnancy</li><li>\u2022 except Yellow fever vaccine.</li><li>\u2022 Ref: Park 27 th ed. Pg 111</li><li>\u2022 Ref:</li><li>\u2022 Park 27 th ed. Pg 111</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a2b595d4",
      "audio": ""
    },
    {
      "text": "A 7-year-old child arrives at your outpatient department with symptoms of fever, malaise, and a vesicular rash that started a day ago. The child has close contacts at home who are susceptible to this illness: a 2-year-old sibling and a mother who is on immunosuppressive therapy. In such a scenario, managing the health of these contacts is crucial to prevent the spread of the illness. What is the most appropriate management strategy for the mother and the sibling in this case?",
      "options": [
        {
          "label": "A",
          "text": "Isolate the infected child and observe for symptoms among contacts",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vaccinate the sibling and give immunoglobulins to the mother",
          "correct": false
        },
        {
          "label": "C",
          "text": "Provide immunoglobulin to both mother and sibling",
          "correct": true
        },
        {
          "label": "D",
          "text": "Give immunoglobulin and vaccine for both",
          "correct": false
        }
      ],
      "correct_answer": "C. Provide immunoglobulin to both mother and sibling",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/24/image-20231024125056-1.jpeg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Provide immunoglobulin to both mother and sibling.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The described child likely has varicella (chickenpox) given the presentation of fever and a vesicular rash . Given the exposure to a vesicular rash illness (possibly varicella or chickenpox), and considering the mother's immunosuppressed state and the young age of the sibling , the administration of immunoglobulin is the most appropriate management . Immunoglobulin can help to prevent or reduce the severity of the illness in these susceptible contacts .</li><li>\u2022 child</li><li>\u2022 varicella (chickenpox)</li><li>\u2022 fever and a vesicular rash</li><li>\u2022 exposure</li><li>\u2022 vesicular rash illness</li><li>\u2022 mother's immunosuppressed state</li><li>\u2022 young age</li><li>\u2022 sibling</li><li>\u2022 administration</li><li>\u2022 immunoglobulin</li><li>\u2022 appropriate management</li><li>\u2022 prevent</li><li>\u2022 reduce the severity</li><li>\u2022 illness</li><li>\u2022 susceptible contacts</li><li>\u2022 Management of Contacts of a Varicella case -</li><li>\u2022 Management of Contacts of a Varicella case -</li><li>\u2022 Isolation for 6 days after onset of rash. Varicella vaccination (live attenuated) is useful, if given to susceptible contacts within 5 days (preferably 72 hours) of first exposure . High-risk susceptible contacts where vaccination is not indicated , such as neonates, pregnancy , and immunosuppressed persons, VZIG for High risk susceptible contacts - within 72 hours of exposure. VZIG Dose: 1.25\u20135.0 mL intramuscularly (15-25 units/kg BW).</li><li>\u2022 Isolation for 6 days after onset of rash.</li><li>\u2022 Isolation</li><li>\u2022 6 days after onset of rash.</li><li>\u2022 Varicella vaccination (live attenuated) is useful, if given to susceptible contacts within 5 days (preferably 72 hours) of first exposure . High-risk susceptible contacts where vaccination is not indicated , such as neonates, pregnancy , and immunosuppressed persons,</li><li>\u2022 Varicella vaccination</li><li>\u2022 susceptible contacts</li><li>\u2022 5 days</li><li>\u2022 first exposure</li><li>\u2022 High-risk</li><li>\u2022 susceptible contacts</li><li>\u2022 not indicated</li><li>\u2022 neonates, pregnancy</li><li>\u2022 immunosuppressed persons,</li><li>\u2022 VZIG for High risk susceptible contacts - within 72 hours of exposure. VZIG Dose: 1.25\u20135.0 mL intramuscularly (15-25 units/kg BW).</li><li>\u2022 VZIG</li><li>\u2022 High risk susceptible contacts</li><li>\u2022 72 hours</li><li>\u2022 exposure.</li><li>\u2022 VZIG</li><li>\u2022 1.25\u20135.0 mL</li><li>\u2022 intramuscularly</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 VZIg to close contacts who are susceptible and at high risk (such as an immunosuppressed mother and a young sibling ) is an appropriate management strategy following exposure to varicella . VZIG for High risk susceptible contacts - within 72 hours of exposure. VZIG Dose: 1.25\u20135.0 mL intramuscularly (15-25 units/kg BW).</li><li>\u2022 VZIg</li><li>\u2022 close contacts</li><li>\u2022 susceptible</li><li>\u2022 high risk</li><li>\u2022 immunosuppressed</li><li>\u2022 mother and a young sibling</li><li>\u2022 appropriate management</li><li>\u2022 exposure to varicella</li><li>\u2022 VZIG</li><li>\u2022 High risk</li><li>\u2022 susceptible contacts</li><li>\u2022 72 hours</li><li>\u2022 VZIG</li><li>\u2022 1.25\u20135.0 mL</li><li>\u2022 intramuscularly</li><li>\u2022 Ref: Park 27th ed, pg 163</li><li>\u2022 Ref:</li><li>\u2022 Park 27th ed, pg 163</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0e772d5a",
      "audio": ""
    }
  ]
}